| 1st level
|
2nd level
|
3rd level
|
4th level
|
5th level
|
Contents
|
| A
|
|
|
|
|
Alimentary tract and metabolism
|
|
|
A01
|
|
|
|
Stomatological preparations
|
|
|
|
A01A
|
|
|
Stomatological preparations
|
|
|
|
|
A01AA
|
|
Caries prophylactic agents
|
|
|
|
|
|
A01AA01
|
Sodium fluoride
|
|
|
|
|
|
A01AA02
|
Sodium monofluorophosphate
|
|
|
|
|
|
A01AA03
|
Olaflur
|
|
|
|
|
|
A01AA04
|
Stannous fluoride
|
|
|
|
|
|
A01AA30
|
Combinations
|
|
|
|
|
|
A01AA51
|
Sodium fluoride, combinations
|
|
|
|
|
A01AB
|
|
Anti-infectives and antiseptics for local oral treatment
|
|
|
|
|
|
A01AB02
|
Hydrogen peroxide
|
|
|
|
|
|
A01AB03
|
Chlorhexidine
|
|
|
|
|
|
A01AB04
|
Amphotericin B
|
|
|
|
|
|
A01AB05
|
Polynoxylin
|
|
|
|
|
|
A01AB06
|
Domiphen
|
|
|
|
|
|
A01AB07
|
Oxyquinoline
|
|
|
|
|
|
A01AB08
|
Neomycin
|
|
|
|
|
|
A01AB09
|
Miconazole
|
|
|
|
|
|
A01AB10
|
Natamycin
|
|
|
|
|
|
A01AB11
|
Various
|
|
|
|
|
|
A01AB12
|
Hexetidine
|
|
|
|
|
|
A01AB13
|
Tetracycline
|
|
|
|
|
|
A01AB14
|
Benzoxonium chloride
|
|
|
|
|
|
A01AB15
|
Tibezonium iodide
|
|
|
|
|
|
A01AB16
|
Mepartricin
|
|
|
|
|
|
A01AB17
|
Metronidazole
|
|
|
|
|
|
A01AB18
|
Clotrimazole
|
|
|
|
|
|
A01AB19
|
Sodium perborate
|
|
|
|
|
|
A01AB21
|
Chlortetracycline
|
|
|
|
|
|
A01AB22
|
Doxycycline
|
|
|
|
|
|
A01AB23
|
Minocycline
|
|
|
|
|
A01AC
|
|
Corticosteroids for local oral treatment
|
|
|
|
|
|
A01AC01
|
Triamcinolone
|
|
|
|
|
|
A01AC02
|
Dexamethasone
|
|
|
|
|
|
A01AC03
|
Hydrocortisone
|
|
|
|
|
|
A01AC54
|
Prednisolone, combinations
|
|
|
|
|
A01AD
|
|
Other agents for local oral treatment
|
|
|
|
|
|
A01AD01
|
Epinephrine
|
|
|
|
|
|
A01AD02
|
Benzydamine
|
|
|
|
|
|
A01AD05
|
Acetylsalicylic acid
|
|
|
|
|
|
A01AD06
|
Adrenalone
|
|
|
|
|
|
A01AD07
|
Amlexanox
|
|
|
|
|
|
A01AD08
|
Becaplermin
|
|
|
|
|
|
A01AD11
|
Various
|
|
|
A02
|
|
|
|
Drugs for acid related disorders
|
|
|
|
A02A
|
|
|
Antacids
|
|
|
|
|
A02AA
|
|
Magnesium compounds
|
|
|
|
|
|
A02AA01
|
Magnesium carbonate
|
|
|
|
|
|
A02AA02
|
Magnesium oxide
|
|
|
|
|
|
A02AA03
|
Magnesium peroxide
|
|
|
|
|
|
A02AA04
|
Magnesium hydroxide
|
|
|
|
|
|
A02AA05
|
Magnesium silicate
|
|
|
|
|
|
A02AA10
|
Combinations
|
|
|
|
|
A02AB
|
|
Aluminium compounds
|
|
|
|
|
|
A02AB01
|
Aluminium hydroxide
|
|
|
|
|
|
A02AB02
|
Algeldrate
|
|
|
|
|
|
A02AB03
|
Aluminium phosphate
|
|
|
|
|
|
A02AB04
|
Dihydroxialumini sodium carbonate
|
|
|
|
|
|
A02AB05
|
Aluminium acetoacetate
|
|
|
|
|
|
A02AB06
|
Aloglutamol
|
|
|
|
|
|
A02AB07
|
Aluminium glycinate
|
|
|
|
|
|
A02AB10
|
Combinations
|
|
|
|
|
A02AC
|
|
Calcium compounds
|
|
|
|
|
|
A02AC01
|
Calcium carbonate
|
|
|
|
|
|
A02AC02
|
Calcium silicate
|
|
|
|
|
|
A02AC10
|
Combinations
|
|
|
|
|
A02AD
|
|
Combinations and complexes of aluminium, calcium and magnesium compounds
|
|
|
|
|
|
A02AD01
|
Ordinary salt combinations
|
|
|
|
|
|
A02AD02
|
Magaldrate
|
|
|
|
|
|
A02AD03
|
Almagate
|
|
|
|
|
|
A02AD04
|
Hydrotalcite
|
|
|
|
|
|
A02AD05
|
Almasilate
|
|
|
|
|
A02AF
|
|
Antacids with antiflatulents
|
|
|
|
|
|
A02AF01
|
Magaldrate and antiflatulents
|
|
|
|
|
|
A02AF02
|
Ordinary salt combinations and antiflatulents
|
|
|
|
|
A02AG
|
|
Antacids with antispasmodics
|
|
|
|
|
|
|
Empty
|
|
|
|
|
A02AH
|
|
Antacids with sodium bicarbonate
|
|
|
|
|
|
|
Empty
|
|
|
|
|
A02AX
|
|
Antacids, other combinations
|
|
|
|
|
|
|
Empty
|
|
|
|
A02B
|
|
|
Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
|
|
|
|
|
A02BA
|
|
H2-receptor antagonists
|
|
|
|
|
|
A02BA01
|
Cimetidine
|
|
|
|
|
|
A02BA02
|
Ranitidine
|
|
|
|
|
|
A02BA03
|
Famotidine
|
|
|
|
|
|
A02BA04
|
Nizatidine
|
|
|
|
|
|
A02BA05
|
Niperotidine
|
|
|
|
|
|
A02BA06
|
Roxatidine
|
|
|
|
|
|
A02BA07
|
Ranitidine bismuth citrate
|
|
|
|
|
|
A02BA08
|
Lafutidine
|
|
|
|
|
|
A02BA51
|
Cimetidine, combinations
|
|
|
|
|
|
A02BA53
|
Famotidine, combinations
|
|
|
|
|
A02BB
|
|
Prostaglandins
|
|
|
|
|
|
A02BB01
|
Misoprostol
|
|
|
|
|
|
A02BB02
|
Enprostil
|
|
|
|
|
A02BC
|
|
Proton pump inhibitors
|
|
|
|
|
|
A02BC01
|
Omeprazole
|
|
|
|
|
|
A02BC02
|
Pantoprazole
|
|
|
|
|
|
A02BC03
|
Lansoprazole
|
|
|
|
|
|
A02BC04
|
Rabeprazole
|
|
|
|
|
|
A02BC05
|
Esomeprazole
|
|
|
|
|
|
A02BC06
|
Dexlansoprazole
|
|
|
|
|
A02BD
|
|
Combinations for eradication of Helicobacter pylori
|
|
|
|
|
|
A02BD01
|
Omeprazole, amoxicillin and metronidazole
|
|
|
|
|
|
A02BD02
|
Lansoprazole, tetracycline and metronidazole
|
|
|
|
|
|
A02BD03
|
Lansoprazole, amoxicillin and metronidazole
|
|
|
|
|
|
A02BD04
|
Pantoprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD05
|
Omeprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD06
|
Esomeprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD07
|
Lansoprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD08
|
Bismuth subcitrate, tetracycline and metronidazole
|
|
|
|
|
A02BX
|
|
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
|
|
|
|
|
|
A02BX01
|
Carbenoxolone
|
|
|
|
|
|
A02BX02
|
Sucralfate
|
|
|
|
|
|
A02BX03
|
Pirenzepine
|
|
|
|
|
|
A02BX04
|
Methiosulfonium chloride
|
|
|
|
|
|
A02BX05
|
Bismuth subcitrate
|
|
|
|
|
|
A02BX06
|
Proglumide
|
|
|
|
|
|
A02BX07
|
Gefarnate
|
|
|
|
|
|
A02BX08
|
Sulglicotide
|
|
|
|
|
|
A02BX09
|
Acetoxolone
|
|
|
|
|
|
A02BX10
|
Zolimidine
|
|
|
|
|
|
A02BX11
|
Troxipide
|
|
|
|
|
|
A02BX12
|
Bismuth subnitrate
|
|
|
|
|
|
A02BX13
|
Alginic acid
|
|
|
|
|
|
A02BX51
|
Carbenoxolone, combinations excluding psycholeptics
|
|
|
|
|
|
A02BX71
|
Carbenoxolone, combinations with psycholeptics
|
|
|
|
|
|
A02BX77
|
Gefarnate, combinations with psycholeptics
|
|
|
|
A02X
|
|
|
Other drugs for acid related disorders
|
|
|
|
|
|
|
Empty
|
|
|
A03
|
|
|
|
Drugs for functional gastrointestinal disorders
|
|
|
|
A03A
|
|
|
Drugs for functional gastrointestinal disorders
|
|
|
|
|
A03AA
|
|
Synthetic anticholinergics, esters with tertiary amino group
|
|
|
|
|
|
A03AA01
|
Oxyphencyclimine
|
|
|
|
|
|
A03AA03
|
Camylofin
|
|
|
|
|
|
A03AA04
|
Mebeverine
|
|
|
|
|
|
A03AA05
|
Trimebutine
|
|
|
|
|
|
A03AA06
|
Rociverine
|
|
|
|
|
|
A03AA07
|
Dicycloverine
|
|
|
|
|
|
A03AA08
|
Dihexyverine
|
|
|
|
|
|
A03AA09
|
Difemerine
|
|
|
|
|
|
A03AA30
|
Piperidolate
|
|
|
|
|
A03AB
|
|
Synthetic anticholinergics, quaternary ammonium compounds
|
|
|
|
|
|
A03AB01
|
Benzilone
|
|
|
|
|
|
A03AB02
|
Glycopyrronium
|
|
|
|
|
|
A03AB03
|
Oxyphenonium
|
|
|
|
|
|
A03AB04
|
Penthienate
|
|
|
|
|
|
A03AB05
|
Propantheline
|
|
|
|
|
|
A03AB06
|
Otilonium bromide
|
|
|
|
|
|
A03AB07
|
Methantheline
|
|
|
|
|
|
A03AB08
|
Tridihexethyl
|
|
|
|
|
|
A03AB09
|
Isopropamide
|
|
|
|
|
|
A03AB10
|
Hexocyclium
|
|
|
|
|
|
A03AB11
|
Poldine
|
|
|
|
|
|
A03AB12
|
Mepenzolate
|
|
|
|
|
|
A03AB13
|
Bevonium
|
|
|
|
|
|
A03AB14
|
Pipenzolate
|
|
|
|
|
|
A03AB15
|
Diphemanil
|
|
|
|
|
|
A03AB16
|
(2-benzhydryloxyethyl)diethyl-methylammonium iodide
|
|
|
|
|
|
A03AB17
|
Tiemonium iodide
|
|
|
|
|
|
A03AB18
|
Prifinium bromide
|
|
|
|
|
|
A03AB19
|
Timepidium bromide
|
|
|
|
|
|
A03AB21
|
Fenpiverinium
|
|
|
|
|
|
A03AB53
|
Oxyphenonium, combinations
|
|
|
|
|
A03AC
|
|
Synthetic antispasmodics, amides with tertiary amines
|
|
|
|
|
|
A03AC02
|
Dimethylaminopropionylphenothiazine
|
|
|
|
|
|
A03AC04
|
Nicofetamide
|
|
|
|
|
|
A03AC05
|
Tiropramide
|
|
|
|
|
A03AD
|
|
Papaverine and derivatives
|
|
|
|
|
|
A03AD01
|
Papaverine
|
|
|
|
|
|
A03AD02
|
Drotaverine
|
|
|
|
|
|
A03AD30
|
Moxaverine
|
|
|
|
|
A03AE
|
|
Serotonin receptor antagonists
|
|
|
|
|
|
A03AE01
|
Alosetron
|
|
|
|
|
|
A03AE03
|
Cilansetron
|
|
|
|
|
A03AX
|
|
Other drugs for functional gastrointestinal disorders
|
|
|
|
|
|
A03AX01
|
Fenpiprane
|
|
|
|
|
|
A03AX02
|
Diisopromine
|
|
|
|
|
|
A03AX03
|
Chlorbenzoxamine
|
|
|
|
|
|
A03AX04
|
Pinaverium
|
|
|
|
|
|
A03AX05
|
Fenoverine
|
|
|
|
|
|
A03AX06
|
Idanpramine
|
|
|
|
|
|
A03AX07
|
Proxazole
|
|
|
|
|
|
A03AX08
|
Alverine
|
|
|
|
|
|
A03AX09
|
Trepibutone
|
|
|
|
|
|
A03AX10
|
Isometheptene
|
|
|
|
|
|
A03AX11
|
Caroverine
|
|
|
|
|
|
A03AX12
|
Phloroglucinol
|
|
|
|
|
|
A03AX13
|
Silicones
|
|
|
|
|
|
A03AX30
|
Trimethyldiphenylpropylamine
|
|
|
|
|
|
A03AX58
|
Alverine, combinations
|
|
|
|
A03B
|
|
|
Belladonna and derivatives, plain
|
|
|
|
|
A03BA
|
|
Belladonna alkaloids, tertiary amines
|
|
|
|
|
|
A03BA01
|
Atropine
|
|
|
|
|
|
A03BA03
|
Hyoscyamine
|
|
|
|
|
|
A03BA04
|
Belladonna total alkaloids
|
|
|
|
|
A03BB
|
|
Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
|
|
|
|
|
|
A03BB01
|
Butylscopolamine
|
|
|
|
|
|
A03BB02
|
Methylatropine
|
|
|
|
|
|
A03BB03
|
Methylscopolamine
|
|
|
|
|
|
A03BB04
|
Fentonium
|
|
|
|
|
|
A03BB05
|
Cimetropium bromide
|
|
|
|
A03C
|
|
|
Antispasmodics in combination with psycholeptics
|
|
|
|
|
A03CA
|
|
Synthetic anticholinergic agents in combination with psycholeptics
|
|
|
|
|
|
A03CA01
|
Isopropamide and psycholeptics
|
|
|
|
|
|
A03CA02
|
Clidinium and psycholeptics
|
|
|
|
|
|
A03CA03
|
Oxyphencyclimine and psycholeptics
|
|
|
|
|
|
A03CA04
|
Otilonium bromide and psycholeptics
|
|
|
|
|
|
A03CA05
|
Glycopyrronium and psycholeptics
|
|
|
|
|
|
A03CA06
|
Bevonium and psycholeptics
|
|
|
|
|
|
A03CA07
|
Ambutonium and psycholeptics
|
|
|
|
|
|
A03CA08
|
Diphemanil and psycholeptics
|
|
|
|
|
|
A03CA30
|
Emepronium and psycholeptics
|
|
|
|
|
|
A03CA34
|
Propantheline and psycholeptics
|
|
|
|
|
A03CB
|
|
Belladonna and derivatives in combination with psycholeptics
|
|
|
|
|
|
A03CB01
|
Methylscopolamine and psycholeptics
|
|
|
|
|
|
A03CB02
|
Belladonna total alkaloids and psycholeptics
|
|
|
|
|
|
A03CB03
|
Atropine and psycholeptics
|
|
|
|
|
|
A03CB04
|
Methylhomatropine and psycholeptics
|
|
|
|
|
|
A03CB31
|
Hyoscyamine and psycholeptics
|
|
|
|
|
A03CC
|
|
Other antispasmodics in combination with psycholeptics
|
|
|
|
|
|
|
empty
|
|
|
|
A03D
|
|
|
Antispasmodics in combination with analgesics
|
|
|
|
|
A03DA
|
|
Synthetic anticholinergic agents in combination with analgesics
|
|
|
|
|
|
A03DA01
|
Tropenzilone and analgesics
|
|
|
|
|
|
A03DA02
|
Pitofenone and analgesics
|
|
|
|
|
|
A03DA03
|
Bevonium and analgesics
|
|
|
|
|
|
A03DA04
|
Ciclonium and analgesics
|
|
|
|
|
|
A03DA05
|
Camylofin and analgesics
|
|
|
|
|
|
A03DA06
|
Trospium and analgesics
|
|
|
|
|
|
A03DA07
|
Tiemonium iodide and analgesics
|
|
|
|
|
A03DB
|
|
Belladonna and derivatives in combination with analgesics
|
|
|
|
|
|
A03DB04
|
Butylscopolamine and analgesics
|
|
|
|
|
A03DC
|
|
Other antispasmodics in combination with analgesics
|
|
|
|
|
|
|
empty
|
|
|
|
A03E
|
|
|
Antispasmodics and anticholinergics in combination with other drugs
|
|
|
|
|
A03EA
|
|
Antispasmodics, psycholeptics and analgesics in combination
|
|
|
|
|
|
|
empty
|
|
|
|
|
A03ED
|
|
Antispasmodics in combination with other drugs
|
|
|
|
|
|
|
empty
|
|
|
|
A03F
|
|
|
Propulsives
|
|
|
|
|
A03FA
|
|
Propulsives
|
|
|
|
|
|
A03FA01
|
Metoclopramide
|
|
|
|
|
|
A03FA02
|
Cisapride
|
|
|
|
|
|
A03FA03
|
Domperidone
|
|
|
|
|
|
A03FA04
|
Bromopride
|
|
|
|
|
|
A03FA05
|
Alizapride
|
|
|
|
|
|
A03FA06
|
Clebopride
|
|
|
A04
|
|
|
|
Antiemetics and antinauseants
|
|
|
|
A04A
|
|
|
Antiemetics and antinauseants
|
|
|
|
|
A04AA
|
|
Serotonin (5-HT3) antagonists
|
|
|
|
|
|
A04AA01
|
Ondansetron
|
|
|
|
|
|
A04AA02
|
Granisetron
|
|
|
|
|
|
A04AA03
|
Tropisetron
|
|
|
|
|
|
A04AA04
|
Dolasetron
|
|
|
|
|
|
A04AA05
|
Palonosetron
|
|
|
|
|
A04AD
|
|
Other antiemetics
|
|
|
|
|
|
A04AD01
|
Scopolamine
|
|
|
|
|
|
A04AD02
|
Cerium oxalate
|
|
|
|
|
|
A04AD04
|
Chlorobutanol
|
|
|
|
|
|
A04AD05
|
Metopimazine
|
|
|
|
|
|
A04AD10
|
Dronabinol
|
|
|
|
|
|
A04AD11
|
Nabilone
|
|
|
|
|
|
A04AD12
|
Aprepitant
|
|
|
|
|
|
A04AD13
|
Casopitant
|
|
|
|
|
|
A04AD51
|
Scopolamine, combinations
|
|
|
|
|
|
A04AD54
|
Chlorobutanol, combinations
|
|
|
A05
|
|
|
|
Bile and liver therapy
|
|
|
|
A05A
|
|
|
Bile therapy
|
|
|
|
|
A05AA
|
|
Bile acid preparations
|
|
|
|
|
|
A05AA01
|
Chenodeoxycholic acid
|
|
|
|
|
|
A05AA02
|
Ursodeoxycholic acid
|
|
|
|
|
|
A05AA03
|
Cholic acid
|
|
|
|
|
A05AB
|
|
Preparations for biliary tract therapy
|
|
|
|
|
|
A05AB01
|
Nicotinyl methylamide
|
|
|
|
|
A05AX
|
|
Other drugs for bile therapy
|
|
|
|
|
|
A05AX01
|
Piprozolin
|
|
|
|
|
|
A05AX02
|
Hymecromone
|
|
|
|
|
|
A05AX03
|
Cyclobutyrol
|
|
|
|
A05B
|
|
|
Liver therapy, lipotropics
|
|
|
|
|
A05BA
|
|
Liver therapy
|
|
|
|
|
|
A05BA01
|
Arginine glutamate
|
|
|
|
|
|
A05BA03
|
Silymarin
|
|
|
|
|
|
A05BA04
|
Citiolone
|
|
|
|
|
|
A05BA05
|
Epomediol
|
|
|
|
|
|
A05BA06
|
Ornithine oxoglutarate
|
|
|
|
|
|
A05BA07
|
Tidiacic arginine
|
|
|
|
|
|
A05BA08
|
Glycyrrhizic acid (glycyrrhizin)
|
|
|
|
A05C
|
|
|
Drugs for bile therapy and lipotropics in combination
|
|
|
|
|
|
|
Empty
|
|
|
A06
|
|
|
|
Drugs for constipation
|
|
|
|
A06A
|
|
|
Drugs for constipation
|
|
|
|
|
A06AA
|
|
Softeners, emollients
|
|
|
|
|
|
A06AA01
|
Liquid paraffin
|
|
|
|
|
|
A06AA02
|
Docusate sodium
|
|
|
|
|
|
A06AA51
|
Liquid paraffin, combinations
|
|
|
|
|
A06AB
|
|
Contact laxatives
|
|
|
|
|
|
A06AB01
|
Oxyphenisatine
|
|
|
|
|
|
A06AB02
|
Bisacodyl
|
|
|
|
|
|
A06AB03
|
Dantron
|
|
|
|
|
|
A06AB04
|
Phenolphthalein
|
|
|
|
|
|
A06AB05
|
Castor oil
|
|
|
|
|
|
A06AB06
|
Senna glycosides
|
|
|
|
|
|
A06AB07
|
Cascara
|
|
|
|
|
|
A06AB08
|
Sodium picosulfate
|
|
|
|
|
|
A06AB09
|
Bisoxatin
|
|
|
|
|
|
A06AB20
|
Contact laxatives in combination
|
|
|
|
|
|
A06AB30
|
Contact laxatives in combination with belladonna alkaloids
|
|
|
|
|
|
A06AB52
|
Bisacodyl, combinations
|
|
|
|
|
|
A06AB53
|
Dantron, combinations
|
|
|
|
|
|
A06AB56
|
Senna glycosides, combinations
|
|
|
|
|
|
A06AB57
|
Cascara, combinations
|
|
|
|
|
|
A06AB58
|
Sodium picosulfate, combinations
|
|
|
|
|
A06AC
|
|
Bulk-forming laxatives
|
|
|
|
|
|
A06AC01
|
Ispaghula (psylla seeds)
|
|
|
|
|
|
A06AC02
|
Ethulose
|
|
|
|
|
|
A06AC03
|
Sterculia
|
|
|
|
|
|
A06AC05
|
Linseed
|
|
|
|
|
|
A06AC06
|
Methylcellulose
|
|
|
|
|
|
A06AC07
|
Triticum (wheat fibre)
|
|
|
|
|
|
A06AC08
|
Polycarbophil calcium
|
|
|
|
|
|
A06AC51
|
Ispaghula, combinations
|
|
|
|
|
|
A06AC53
|
Sterculia, combinations
|
|
|
|
|
|
A06AC55
|
Linseed, combinations
|
|
|
|
|
A06AD
|
|
Osmotically acting laxatives
|
|
|
|
|
|
A06AD01
|
Magnesium carbonate
|
|
|
|
|
|
A06AD02
|
Magnesium oxide
|
|
|
|
|
|
A06AD03
|
Magnesium peroxide
|
|
|
|
|
|
A06AD04
|
Magnesium sulfate
|
|
|
|
|
|
A06AD10
|
Mineral salts in combination
|
|
|
|
|
|
A06AD11
|
Lactulose
|
|
|
|
|
|
A06AD12
|
Lactitol
|
|
|
|
|
|
A06AD13
|
Sodium sulfate
|
|
|
|
|
|
A06AD14
|
Pentaerithrityl
|
|
|
|
|
|
A06AD15
|
Macrogol
|
|
|
|
|
|
A06AD16
|
Mannitol
|
|
|
|
|
|
A06AD17
|
Sodium phosphate
|
|
|
|
|
|
A06AD18
|
Sorbitol
|
|
|
|
|
|
A06AD19
|
Magnesium citrate
|
|
|
|
|
|
A06AD21
|
Sodium tartrate
|
|
|
|
|
|
A06AD61
|
Lactulose, combinations
|
|
|
|
|
|
A06AD65
|
Macrogol, combinations
|
|
|
|
|
A06AG
|
|
Enemas
|
|
|
|
|
|
A06AG01
|
Sodium phosphate
|
|
|
|
|
|
A06AG02
|
Bisacodyl
|
|
|
|
|
|
A06AG03
|
Dantron, including combinations
|
|
|
|
|
|
A06AG04
|
Glycerol
|
|
|
|
|
|
A06AG06
|
Oil
|
|
|
|
|
|
A06AG07
|
Sorbitol
|
|
|
|
|
|
A06AG10
|
Docusate sodium, including combinations
|
|
|
|
|
|
A06AG11
|
Laurilsulfate, including combinations
|
|
|
|
|
|
A06AG20
|
Combinations
|
|
|
|
|
A06AH
|
|
Peripheral opioid receptor antagonists
|
|
|
|
|
|
A06AH01
|
Methylnaltrexone bromide
|
|
|
|
|
|
A06AH02
|
Alvimopan
|
|
|
|
|
A06AX
|
|
Other drugs for constipation
|
|
|
|
|
|
A06AX01
|
Glycerol
|
|
|
|
|
|
A06AX02
|
Carbon dioxide producing drugs
|
|
|
|
|
|
A06AX03
|
Lubiprostone
|
|
|
|
|
|
A06AX04
|
Linaclotide
|
|
|
|
|
|
A06AX05
|
Prucalopride
|
|
|
|
|
|
A06AX06
|
Tegaserod
|
|
|
A07
|
|
|
|
Antidiarrheals, intestinal anti-inflammatory/anti-infective agents
|
|
|
|
A07A
|
|
|
Intestinal anti-infectives
|
|
|
|
|
A07AA
|
|
Antibiotics
|
|
|
|
|
|
A07AA01
|
Neomycin
|
|
|
|
|
|
A07AA02
|
Nystatin
|
|
|
|
|
|
A07AA03
|
Natamycin
|
|
|
|
|
|
A07AA04
|
Streptomycin
|
|
|
|
|
|
A07AA05
|
Polymyxin B
|
|
|
|
|
|
A07AA06
|
Paromomycin
|
|
|
|
|
|
A07AA07
|
Amphotericin B
|
|
|
|
|
|
A07AA08
|
Kanamycin
|
|
|
|
|
|
A07AA09
|
Vancomycin
|
|
|
|
|
|
A07AA10
|
Colistin
|
|
|
|
|
|
A07AA11
|
Rifaximin
|
|
|
|
|
|
A07AA12
|
Fidaxomicin
|
|
|
|
|
|
A07AA51
|
Neomycin, combinations
|
|
|
|
|
|
A07AA54
|
Streptomycin, combinations
|
|
|
|
|
A07AB
|
|
Sulfonamides
|
|
|
|
|
|
A07AB02
|
Phthalylsulfathiazole
|
|
|
|
|
|
A07AB03
|
Sulfaguanidine
|
|
|
|
|
|
A07AB04
|
Succinylsulfathiazole
|
|
|
|
|
A07AC
|
|
Imidazole derivatives
|
|
|
|
|
|
A07AC01
|
Miconazole
|
|
|
|
|
A07AX
|
|
Other intestinal anti-infectives
|
|
|
|
|
|
A07AX01
|
Broxyquinoline
|
|
|
|
|
|
A07AX02
|
Acetarsol
|
|
|
|
|
|
A07AX03
|
Nifuroxazide
|
|
|
|
|
|
A07AX04
|
Nifurzide
|
|
|
|
A07B
|
|
|
Intestinal adsorbents
|
|
|
|
|
A07BA
|
|
Charcoal preparations
|
|
|
|
|
|
A07BA01
|
Medicinal charcoal
|
|
|
|
|
|
A07BA51
|
Medicinal charcoal, combinations
|
|
|
|
|
A07BB
|
|
Bismuth preparations
|
|
|
|
|
|
|
empty
|
|
|
|
|
A07BC
|
|
Other intestinal adsorbents
|
|
|
|
|
|
A07BC01
|
Pectin
|
|
|
|
|
|
A07BC02
|
Kaolin
|
|
|
|
|
|
A07BC03
|
Crospovidone
|
|
|
|
|
|
A07BC04
|
Attapulgite
|
|
|
|
|
|
A07BC05
|
Diosmectite
|
|
|
|
|
|
A07BC30
|
Combinations
|
|
|
|
|
|
A07BC54
|
Attapulgite, combinations
|
|
|
|
A07C
|
|
|
Electrolytes with carbohydrates
|
|
|
|
|
A07CA
|
|
Oral rehydration salt formulations
|
|
|
|
|
|
|
human ATC classification.
|
|
|
|
A07D
|
|
|
Antipropulsives
|
|
|
|
|
A07DA
|
|
Antipropulsives
|
|
|
|
|
|
A07DA01
|
Diphenoxylate
|
|
|
|
|
|
A07DA02
|
Opium
|
|
|
|
|
|
A07DA03
|
Loperamide
|
|
|
|
|
|
A07DA04
|
Difenoxin
|
|
|
|
|
|
A07DA05
|
Loperamide oxide
|
|
|
|
|
|
A07DA52
|
Morphine, combinations
|
|
|
|
|
|
A07DA53
|
Loperamide, combinations
|
|
|
|
A07E
|
|
|
Intestinal anti-inflammatory agents
|
|
|
|
|
A07EA
|
|
Corticosteroids acting locally
|
|
|
|
|
|
A07EA01
|
Prednisolone
|
|
|
|
|
|
A07EA02
|
Hydrocortisone
|
|
|
|
|
|
A07EA03
|
Prednisone
|
|
|
|
|
|
A07EA04
|
Betamethasone
|
|
|
|
|
|
A07EA05
|
Tixocortol
|
|
|
|
|
|
A07EA06
|
Budesonide
|
|
|
|
|
|
A07EA07
|
Beclometasone
|
|
|
|
|
A07EB
|
|
Antiallergic agents, excluding corticosteroids
|
|
|
|
|
|
A07EB01
|
Cromoglicic acid
|
|
|
|
|
A07EC
|
|
Aminosalicylic acid and similar agents
|
|
|
|
|
|
A07EC01
|
Sulfasalazine
|
|
|
|
|
|
A07EC02
|
Mesalazine
|
|
|
|
|
|
A07EC03
|
Olsalazine
|
|
|
|
|
|
A07EC04
|
Balsalazide
|
|
|
|
A07F
|
|
|
Antidiarrheal micro-organisms
|
|
|
|
|
A07FA
|
|
Antidiarrheal micro-organisms
|
|
|
|
|
|
A07FA01
|
Lactic acid producing organisms
|
|
|
|
|
|
A07FA02
|
Saccharomyces boulardii
|
|
|
|
|
|
A07FA51
|
Lactic acid producing organisms, combinations
|
|
|
|
A07X
|
|
|
Other antidiarrheals
|
|
|
|
|
A07XA
|
|
Other antidiarrheals
|
|
|
|
|
|
A07XA01
|
Albumin tannate
|
|
|
|
|
|
A07XA02
|
Ceratonia
|
|
|
|
|
|
A07XA03
|
Calcium compounds
|
|
|
|
|
|
A07XA04
|
Racecadotril
|
|
|
|
|
|
A07XA51
|
Albumin tannate, combinations
|
|
|
A08
|
|
|
|
Antiobesity preparations, excluding diet products
|
|
|
|
A08A
|
|
|
Antiobesity preparations, excluding diet products
|
|
|
|
|
A08AA
|
|
Centrally acting antiobesity products
|
|
|
|
|
|
A08AA01
|
Phentermine
|
|
|
|
|
|
A08AA02
|
Fenfluramine
|
|
|
|
|
|
A08AA03
|
Amfepramone
|
|
|
|
|
|
A08AA04
|
Dexfenfluramine
|
|
|
|
|
|
A08AA05
|
Mazindol
|
|
|
|
|
|
A08AA06
|
Etilamfetamine
|
|
|
|
|
|
A08AA07
|
Cathine
|
|
|
|
|
|
A08AA08
|
Clobenzorex
|
|
|
|
|
|
A08AA09
|
Mefenorex
|
|
|
|
|
|
A08AA10
|
Sibutramine
|
|
|
|
|
|
A08AA56
|
Ephedrine, combinations
|
|
|
|
|
A08AB
|
|
Peripherally acting antiobesity products
|
|
|
|
|
|
A08AB01
|
Orlistat
|
|
|
|
|
A08AX
|
|
Other antiobesity drugs
|
|
|
|
|
|
A08AX01
|
Rimonabant
|
|
|
A09
|
|
|
|
Digestives,including enzymes
|
|
|
|
A09A
|
|
|
Digestives, including enzymes
|
|
|
|
|
A09AA
|
|
Enzyme preparations
|
|
|
|
|
|
A09AA01
|
Diastase
|
|
|
|
|
|
A09AA02
|
Multienzymes (lipase, protease, etc.)
|
|
|
|
|
|
A09AA03
|
Pepsin
|
|
|
|
|
|
A09AA04
|
Tilactase
|
|
|
|
|
A09AB
|
|
Acid preparations
|
|
|
|
|
|
A09AB01
|
Glutamic acid hydrochloride
|
|
|
|
|
|
A09AB02
|
Betaine hydrochloride
|
|
|
|
|
|
A09AB03
|
Hydrochloric acid
|
|
|
|
|
|
A09AB04
|
Citric acid
|
|
|
|
|
A09AC
|
|
Enzyme and acid preparations, combinations
|
|
|
|
|
|
A09AC01
|
Pepsin and acid preparations
|
|
|
|
|
|
A09AC02
|
Multienzymes and acid preparations
|
|
|
A10
|
|
|
|
Drugs used in diabetes
|
|
|
|
A10A
|
|
|
Insulins and analogues
|
|
|
|
|
A10AB
|
|
Insulins and analogues for injection, fast-acting
|
|
|
|
|
|
A10AB01
|
Insulin (human)
|
|
|
|
|
|
A10AB02
|
Insulin (beef)
|
|
|
|
|
|
A10AB03
|
Insulin (pork)
|
|
|
|
|
|
A10AB04
|
Insulin lispro
|
|
|
|
|
|
A10AB05
|
Insulin aspart
|
|
|
|
|
|
A10AB06
|
Insulin glulisine
|
|
|
|
|
|
A10AB30
|
Combinations
|
|
|
|
|
A10AC
|
|
Insulins and analogues for injection, intermediate-acting
|
|
|
|
|
|
A10AC01
|
Insulin (human)
|
|
|
|
|
|
A10AC02
|
Insulin (beef)
|
|
|
|
|
|
A10AC03
|
Insulin (pork)
|
|
|
|
|
|
A10AC04
|
Insulin lispro
|
|
|
|
|
|
A10AC30
|
Combinations
|
|
|
|
|
A10AD
|
|
Insulins and analogues for injection, intermediate-acting combined with fast-acting
|
|
|
|
|
|
A10AD01
|
Insulin (human)
|
|
|
|
|
|
A10AD02
|
Insulin (beef)
|
|
|
|
|
|
A10AD03
|
Insulin (pork)
|
|
|
|
|
|
A10AD04
|
Insulin lispro
|
|
|
|
|
|
A10AD05
|
Insulin aspart
|
|
|
|
|
|
A10AD30
|
Combinations
|
|
|
|
|
A10AE
|
|
Insulins and analogues for injection, long-acting
|
|
|
|
|
|
A10AE01
|
Insulin (human)
|
|
|
|
|
|
A10AE02
|
Insulin (beef)
|
|
|
|
|
|
A10AE03
|
Insulin (pork)
|
|
|
|
|
|
A10AE04
|
Insulin glargine
|
|
|
|
|
|
A10AE05
|
Insulin detemir
|
|
|
|
|
|
A10AE30
|
Combinations
|
|
|
|
|
A10AF
|
|
Insulins and analogues for inhalation
|
|
|
|
|
|
A10AF01
|
Insulin (human)
|
|
|
|
A10B
|
|
|
Blood glucose lowering drugs, excluding insulins
|
|
|
|
|
A10BA
|
|
Biguanides
|
|
|
|
|
|
A10BA01
|
Phenformin
|
|
|
|
|
|
A10BA02
|
Metformin
|
|
|
|
|
|
A10BA03
|
Buformin
|
|
|
|
|
A10BB
|
|
Sulfonamides, urea derivatives
|
|
|
|
|
|
A10BB01
|
Glibenclamide
|
|
|
|
|
|
A10BB02
|
Chlorpropamide
|
|
|
|
|
|
A10BB03
|
Tolbutamide
|
|
|
|
|
|
A10BB04
|
Glibornuride
|
|
|
|
|
|
A10BB05
|
Tolazamide
|
|
|
|
|
|
A10BB06
|
Carbutamide
|
|
|
|
|
|
A10BB07
|
Glipizide
|
|
|
|
|
|
A10BB08
|
Gliquidone
|
|
|
|
|
|
A10BB09
|
Gliclazide
|
|
|
|
|
|
A10BB10
|
Metahexamide
|
|
|
|
|
|
A10BB11
|
Glisoxepide
|
|
|
|
|
|
A10BB12
|
Glimepiride
|
|
|
|
|
|
A10BB31
|
Acetohexamide
|
|
|
|
|
A10BC
|
|
Sulfonamides (heterocyclic)
|
|
|
|
|
|
A10BC01
|
Glymidine
|
|
|
|
|
A10BD
|
|
Combinations of oral blood glucose lowering drugs
|
|
|
|
|
|
A10BD01
|
Phenformin and sulfonamides
|
|
|
|
|
|
A10BD02
|
Metformin and sulfonamides
|
|
|
|
|
|
A10BD03
|
Metformin and rosiglitazone
|
|
|
|
|
|
A10BD04
|
Glimepiride and rosiglitazone
|
|
|
|
|
|
A10BD05
|
Metformin and pioglitazone
|
|
|
|
|
|
A10BD06
|
Glimepiride and pioglitazone
|
|
|
|
|
|
A10BD07
|
Metformin and sitagliptin
|
|
|
|
|
|
A10BD08
|
Metformin and vildagliptin
|
|
|
|
|
|
A10BD09
|
Pioglitazone and alogliptin
|
|
|
|
|
|
A10BD10
|
Metformin and saxagliptin
|
|
|
|
|
|
A10BD11
|
Metformin and linagliptin
|
|
|
|
|
|
A10BD12
|
Pioglitazone and sitagliptin
|
|
|
|
|
|
A10BD13
|
Metformin and alogliptin
|
|
|
|
|
A10BF
|
|
Alpha glucosidase inhibitors
|
|
|
|
|
|
A10BF01
|
Acarbose
|
|
|
|
|
|
A10BF02
|
Miglitol
|
|
|
|
|
|
A10BF03
|
Voglibose
|
|
|
|
|
A10BG
|
|
Thiazolidinediones
|
|
|
|
|
|
A10BG01
|
Troglitazone
|
|
|
|
|
|
A10BG02
|
Rosiglitazone
|
|
|
|
|
|
A10BG03
|
Pioglitazone
|
|
|
|
|
A10BH
|
|
Dipeptidyl peptidase 4 (DPP-4) inhibitors
|
|
|
|
|
|
A10BH01
|
Sitagliptin
|
|
|
|
|
|
A10BH02
|
Vildagliptin
|
|
|
|
|
|
A10BH03
|
Saxagliptin
|
|
|
|
|
|
A10BH04
|
Alogliptin
|
|
|
|
|
|
A10BH05
|
Linagliptin
|
|
|
|
|
|
A10BH51
|
Sitagliptin and simvastatin
|
|
|
|
|
A10BX
|
|
Other blood glucose lowering drugs, excluding insulins
|
|
|
|
|
|
A10BX01
|
Guar gum
|
|
|
|
|
|
A10BX02
|
Repaglinide
|
|
|
|
|
|
A10BX03
|
Nateglinide
|
|
|
|
|
|
A10BX04
|
Exenatide
|
|
|
|
|
|
A10BX05
|
Pramlintide
|
|
|
|
|
|
A10BX06
|
Benfluorex
|
|
|
|
|
|
A10BX07
|
Liraglutide
|
|
|
|
|
|
A10BX08
|
Mitiglinide
|
|
|
|
|
|
A10BX09
|
Dapagliflozin
|
|
|
|
A10X
|
|
|
Other drugs used in diabetes
|
|
|
|
|
A10XA
|
|
Aldose reductase inhibitors
|
|
|
|
|
|
A10XA01
|
Tolrestat
|
|
|
A11
|
|
|
|
Vitamins
|
|
|
|
A11A
|
|
|
Multivitamins, combinations
|
|
|
|
|
A11AA
|
|
Multivitamins with minerals
|
|
|
|
|
|
A11AA01
|
Multivitamins and iron
|
|
|
|
|
|
A11AA02
|
Multivitamins and calcium
|
|
|
|
|
|
A11AA03
|
Multivitamins and other minerals, including combinations
|
|
|
|
|
|
A11AA04
|
Multivitamins and trace elements
|
|
|
|
|
A11AB
|
|
Multivitamins, other combinations
|
|
|
|
|
|
|
empty
|
|
|
|
A11B
|
|
|
Multivitamins, plain
|
|
|
|
|
A11BA
|
|
Multivitamins, plain
|
|
|
|
|
|
|
empty
|
|
|
|
A11C
|
|
|
Vitamin A and D, including combinations of the two
|
|
|
|
|
A11CA
|
|
Vitamin A, plain
|
|
|
|
|
|
A11CA01
|
Retinol (vitamin A)
|
|
|
|
|
|
A11CA02
|
Betacarotene
|
|
|
|
|
A11CB
|
|
Vitamin A and D in combination
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11CC
|
|
Vitamin D and analogues
|
|
|
|
|
|
A11CC01
|
Ergocalciferol
|
|
|
|
|
|
A11CC02
|
Dihydrotachysterol
|
|
|
|
|
|
A11CC03
|
Alfacalcidol
|
|
|
|
|
|
A11CC04
|
Calcitriol
|
|
|
|
|
|
A11CC05
|
Colecalciferol
|
|
|
|
|
|
A11CC06
|
Calcifediol
|
|
|
|
|
|
A11CC20
|
Combinations
|
|
|
|
A11D
|
|
|
Vitamin B1, plain and in combination with vitamin B6 and B12
|
|
|
|
|
A11DA
|
|
Vitamin B1, plain
|
|
|
|
|
|
A11DA01
|
Thiamine (vitamin B1)
|
|
|
|
|
|
A11DA02
|
Sulbutiamine
|
|
|
|
|
|
A11DA03
|
Benfotiamine
|
|
|
|
|
A11DB
|
|
Vitamin B1 in combination with vitamin B6 and/or vitamin B12
|
|
|
|
|
|
|
empty
|
|
|
|
A11E
|
|
|
Vitamin B-complex, including combinations
|
|
|
|
|
A11EA
|
|
Vitamin B-complex, plain
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11EB
|
|
Vitamin B-complex with vitamin C
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11EC
|
|
Vitamin B-complex with minerals
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11ED
|
|
Vitamin B-complex with anabolic steroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11EX
|
|
Vitamin B-complex, other combinations
|
|
|
|
|
|
|
empty
|
|
|
|
A11G
|
|
|
Ascorbic acid (vitamin C), including combinations
|
|
|
|
|
A11GA
|
|
Ascorbic acid (vitamin C), plain
|
|
|
|
|
|
A11GA01
|
Ascorbic acid (vitamin C)
|
|
|
|
|
A11GB
|
|
Ascorbic acid (vitamin C), combinations
|
|
|
|
|
|
A11GB01
|
Ascorbic acid (vitamin C) and calcium
|
|
|
|
A11H
|
|
|
Other plain vitamin preparations
|
|
|
|
|
A11HA
|
|
Other plain vitamin preparations A11HA01 Nicotinamide
|
|
|
|
|
|
A11HA02
|
Pyridoxine (vitamin B6)
|
|
|
|
|
|
A11HA03
|
Tocopherol (vitamin E)
|
|
|
|
|
|
A11HA04
|
Riboflavin (vitamin B2)
|
|
|
|
|
|
A11HA05
|
Biotin
|
|
|
|
|
|
A11HA06
|
Pyridoxal phosphate
|
|
|
|
|
|
A11HA07
|
Inositol
|
|
|
|
|
|
A11HA08
|
Tocofersolan
|
|
|
|
|
|
A11HA30
|
Dexpanthenol
|
|
|
|
|
|
A11HA31
|
Calcium pantothenate
|
|
|
|
|
|
A11HA32
|
Pantethine
|
|
|
|
A11J
|
|
|
Other vitamin products, combinations
|
|
|
|
|
A11JA
|
|
Combinations of vitamins
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11JB
|
|
Vitamins with minerals
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11JC
|
|
Vitamins, other combinations
|
|
|
|
|
|
|
empty
|
|
|
A12
|
|
|
|
Mineral supplements
|
|
|
|
A12A
|
|
|
Calcium
|
|
|
|
|
A12AA
|
|
Calcium
|
|
|
|
|
|
A12AA01
|
Calcium phosphate
|
|
|
|
|
|
A12AA02
|
Calcium glubionate
|
|
|
|
|
|
A12AA03
|
Calcium gluconate
|
|
|
|
|
|
A12AA04
|
Calcium carbonate
|
|
|
|
|
|
A12AA05
|
Calcium lactate
|
|
|
|
|
|
A12AA06
|
Calcium lactate gluconate
|
|
|
|
|
|
A12AA07
|
Calcium chloride
|
|
|
|
|
|
A12AA08
|
Calcium glycerylphosphate
|
|
|
|
|
|
A12AA09
|
Calcium citrate lysine complex
|
|
|
|
|
|
A12AA10
|
Calcium glucoheptonate
|
|
|
|
|
|
A12AA11
|
Calcium pangamate
|
|
|
|
|
|
A12AA12
|
Calcium acetate anhydrous
|
|
|
|
|
|
A12AA20
|
Calcium (different salts in combination)
|
|
|
|
|
|
A12AA30
|
Calcium laevulate
|
|
|
|
|
A12AX
|
|
Calcium, combinations with vitamin D and/or other drugs
|
|
|
|
|
|
|
empty
|
|
|
|
A12B
|
|
|
Potassium
|
|
|
|
|
A12BA
|
|
Potassium
|
|
|
|
|
|
A12BA01
|
Potassium chloride
|
|
|
|
|
|
A12BA02
|
Potassium citrate
|
|
|
|
|
|
A12BA03
|
Potassium hydrogentartrate
|
|
|
|
|
|
A12BA04
|
Potassium hydrogencarbonate
|
|
|
|
|
|
A12BA05
|
Potassium gluconate
|
|
|
|
|
|
A12BA30
|
Combinations
|
|
|
|
|
|
A12BA51
|
Potassium chloride, combinations
|
|
|
|
A12C
|
|
|
Other mineral supplements
|
|
|
|
|
A12CA
|
|
Sodium
|
|
|
|
|
|
A12CA01
|
Sodium chloride
|
|
|
|
|
|
A12CA02
|
Sodium sulfate
|
|
|
|
|
A12CB
|
|
Zinc
|
|
|
|
|
|
A12CB01
|
Zinc sulfate
|
|
|
|
|
|
A12CB02
|
Zinc gluconate
|
|
|
|
|
|
A12CB03
|
Zinc protein complex
|
|
|
|
|
A12CC
|
|
Magnesium
|
|
|
|
|
|
A12CC01
|
Magnesium chloride
|
|
|
|
|
|
A12CC02
|
Magnesium sulfate
|
|
|
|
|
|
A12CC03
|
Magnesium gluconate
|
|
|
|
|
|
A12CC04
|
Magnesium citrate
|
|
|
|
|
|
A12CC05
|
Magnesium aspartate
|
|
|
|
|
|
A12CC06
|
Magnesium lactate
|
|
|
|
|
|
A12CC07
|
Magnesium levulinate
|
|
|
|
|
|
A12CC08
|
Magnesium pidolate
|
|
|
|
|
|
A12CC09
|
Magnesium orotate
|
|
|
|
|
|
A12CC10
|
Magnesium oxide
|
|
|
|
|
|
A12CC30
|
Magnesium (different salts in combination)
|
|
|
|
|
A12CD
|
|
Fluoride
|
|
|
|
|
|
A12CD01
|
Sodium fluoride
|
|
|
|
|
|
A12CD02
|
Sodium monofluorophosphate
|
|
|
|
|
|
A12CD51
|
Fluoride, combinations
|
|
|
|
|
A12CE
|
|
Selenium
|
|
|
|
|
|
A12CE01
|
Sodium selenate
|
|
|
|
|
|
A12CE02
|
Sodium selenite
|
|
|
|
|
A12CX
|
|
Other mineral products
|
|
|
|
|
|
|
empty
|
|
|
A13
|
|
|
|
Tonics
|
|
|
|
A13A
|
|
|
Tonics
|
|
|
|
|
|
|
empty
|
|
|
A14
|
|
|
|
Anabolic agents for systemic use
|
|
|
|
A14A
|
|
|
Anabolic steroids
|
|
|
|
|
A14AA
|
|
Androstan derivatives
|
|
|
|
|
|
A14AA01
|
Androstanolone
|
|
|
|
|
|
A14AA02
|
Stanozolol
|
|
|
|
|
|
A14AA03
|
Metandienone
|
|
|
|
|
|
A14AA04
|
Metenolone
|
|
|
|
|
|
A14AA05
|
Oxymetholone
|
|
|
|
|
|
A14AA06
|
Quinbolone
|
|
|
|
|
|
A14AA07
|
Prasterone
|
|
|
|
|
|
A14AA08
|
Oxandrolone
|
|
|
|
|
|
A14AA09
|
Norethandrolone
|
|
|
|
|
A14AB
|
|
Estren derivatives
|
|
|
|
|
|
A14AB01
|
Nandrolone
|
|
|
|
|
|
A14AB02
|
Ethylestrenol
|
|
|
|
|
|
A14AB03
|
Oxabolone cipionate
|
|
|
|
A14B
|
|
|
Other anabolic agents
|
|
|
|
|
|
|
empty
|
|
|
A15
|
|
|
|
Appetite stimulants
|
|
|
|
|
|
|
empty
|
|
|
A16
|
|
|
|
Other alimentary tract and metabolism products
|
|
|
|
A16A
|
|
|
Other alimentary tract and metabolism products
|
|
|
|
|
A16AA
|
|
Amino acids and derivatives
|
|
|
|
|
|
A16AA01
|
Levocarnitine
|
|
|
|
|
|
A16AA02
|
Ademetionine
|
|
|
|
|
|
A16AA03
|
Levoglutamide
|
|
|
|
|
|
A16AA04
|
Mercaptamine
|
|
|
|
|
|
A16AA05
|
Carglumic acid
|
|
|
|
|
|
A16AA06
|
Betaine
|
|
|
|
|
A16AB
|
|
Enzymes
|
|
|
|
|
|
A16AB01
|
Alglucerase
|
|
|
|
|
|
A16AB02
|
Imiglucerase
|
|
|
|
|
|
A16AB03
|
Agalsidase alfa
|
|
|
|
|
|
A16AB04
|
Agalsidase beta
|
|
|
|
|
|
A16AB05
|
Laronidase
|
|
|
|
|
|
A16AB06
|
Sacrosidase
|
|
|
|
|
|
A16AB07
|
Alglucosidase alfa
|
|
|
|
|
|
A16AB08
|
Galsulfase
|
|
|
|
|
|
A16AB09
|
Idursulfase
|
|
|
|
|
|
A16AB10
|
Velaglucerase alfa
|
|
|
|
|
|
A16AB11
|
Taliglucerase alfa
|
|
|
|
|
A16AX
|
|
Various alimentary tract and metabolism products
|
|
|
|
|
|
A16AX01
|
Thioctic acid
|
|
|
|
|
|
A16AX02
|
Anethole trithione
|
|
|
|
|
|
A16AX03
|
Sodium phenylbutyrate
|
|
|
|
|
|
A16AX04
|
Nitisinone
|
|
|
|
|
|
A16AX05
|
Zinc acetate
|
|
|
|
|
|
A16AX06
|
Miglustat
|
|
|
|
|
|
A16AX07
|
Sapropterin
|
|
|
|
|
|
A16AX08
|
Teduglutide
|
|
|
|
|
|
A16AX09
|
Glycerol phenylbutyrate
|
| B
|
|
|
|
|
Blood and blood forming organs
|
|
|
B01
|
|
|
|
Antithrombotic agents
|
|
|
|
B01A
|
|
|
Antithrombotic agents
|
|
|
|
|
B01AA
|
|
Vitamin K antagonists
|
|
|
|
|
|
B01AA01
|
Dicoumarol
|
|
|
|
|
|
B01AA02
|
Phenindione
|
|
|
|
|
|
B01AA03
|
Warfarin
|
|
|
|
|
|
B01AA04
|
Phenprocoumon
|
|
|
|
|
|
B01AA07
|
Acenocoumarol
|
|
|
|
|
|
B01AA08
|
Ethyl biscoumacetate
|
|
|
|
|
|
B01AA09
|
Clorindione
|
|
|
|
|
|
B01AA10
|
Diphenadione
|
|
|
|
|
|
B01AA11
|
Tioclomarol
|
|
|
|
|
|
B01AA12
|
Fluindione
|
|
|
|
|
B01AB
|
|
Heparin group
|
|
|
|
|
|
B01AB01
|
Heparin
|
|
|
|
|
|
B01AB02
|
Antithrombin III
|
|
|
|
|
|
B01AB04
|
Dalteparin
|
|
|
|
|
|
B01AB05
|
Enoxaparin
|
|
|
|
|
|
B01AB06
|
Nadroparin
|
|
|
|
|
|
B01AB07
|
Parnaparin
|
|
|
|
|
|
B01AB08
|
Reviparin
|
|
|
|
|
|
B01AB09
|
Danaparoid
|
|
|
|
|
|
B01AB10
|
Tinzaparin
|
|
|
|
|
|
B01AB11
|
Sulodexide
|
|
|
|
|
|
B01AB12
|
Bemiparin
|
|
|
|
|
|
B01AB51
|
Heparin, combinations
|
|
|
|
|
B01AC
|
|
Platelet aggregation inhibitors excluding heparin
|
|
|
|
|
|
B01AC01
|
Ditazole
|
|
|
|
|
|
B01AC02
|
Cloricromen
|
|
|
|
|
|
B01AC03
|
Picotamide
|
|
|
|
|
|
B01AC04
|
Clopidogrel
|
|
|
|
|
|
B01AC05
|
Ticlopidine
|
|
|
|
|
|
B01AC06
|
Acetylsalicylic acid
|
|
|
|
|
|
B01AC07
|
Dipyridamole
|
|
|
|
|
|
B01AC08
|
Carbasalate calcium
|
|
|
|
|
|
B01AC09
|
Epoprostenol
|
|
|
|
|
|
B01AC10
|
Indobufen
|
|
|
|
|
|
B01AC11
|
Iloprost
|
|
|
|
|
|
B01AC13
|
Abciximab
|
|
|
|
|
|
B01AC15
|
Aloxiprin
|
|
|
|
|
|
B01AC16
|
Eptifibatide
|
|
|
|
|
|
B01AC17
|
Tirofiban
|
|
|
|
|
|
B01AC18
|
Triflusal
|
|
|
|
|
|
B01AC19
|
Beraprost
|
|
|
|
|
|
B01AC21
|
Treprostinil
|
|
|
|
|
|
B01AC22
|
Prasugrel
|
|
|
|
|
|
B01AC23
|
Cilostazol
|
|
|
|
|
|
B01AC24
|
Ticagrelor
|
|
|
|
|
|
B01AC30
|
Combinations
|
|
|
|
|
|
B01AC56
|
Acetylsalicylic acid and esomeprazole
|
|
|
|
|
B01AD
|
|
Enzymes
|
|
|
|
|
|
B01AD01
|
Streptokinase
|
|
|
|
|
|
B01AD02
|
Alteplase
|
|
|
|
|
|
B01AD03
|
Anistreplase
|
|
|
|
|
|
B01AD04
|
Urokinase
|
|
|
|
|
|
B01AD05
|
Fibrinolysin
|
|
|
|
|
|
B01AD06
|
Brinase
|
|
|
|
|
|
B01AD07
|
Reteplase
|
|
|
|
|
|
B01AD08
|
Saruplase
|
|
|
|
|
|
B01AD09
|
Ancrod
|
|
|
|
|
|
B01AD10
|
Drotrecogin alfa (activated)
|
|
|
|
|
|
B01AD11
|
Tenecteplase
|
|
|
|
|
|
B01AD12
|
Protein C
|
|
|
|
|
B01AE
|
|
Direct thrombin inhibitors
|
|
|
|
|
|
B01AE01
|
Desirudin
|
|
|
|
|
|
B01AE02
|
Lepirudin
|
|
|
|
|
|
B01AE03
|
Argatroban
|
|
|
|
|
|
B01AE04
|
Melagatran
|
|
|
|
|
|
B01AE05
|
Ximelagatran
|
|
|
|
|
|
B01AE06
|
Bivalirudin
|
|
|
|
|
|
B01AE07
|
Dabigatran etexilate
|
|
|
|
|
B01AF
|
|
Direct factor Xa inhibitors
|
|
|
|
|
|
B01AF01
|
Rivaroxaban
|
|
|
|
|
|
B01AF02
|
Apixaban
|
|
|
|
|
B01AX
|
|
Other antithrombotic agents
|
|
|
|
|
|
B01AX01
|
Defibrotide
|
|
|
|
|
|
B01AX04
|
Dermatan sulfate
|
|
|
|
|
|
B01AX05
|
Fondaparinux
|
|
|
B02
|
|
|
|
Antihemorrhagics
|
|
|
|
B02A
|
|
|
Antifibrinolytics
|
|
|
|
|
B02AA
|
|
Amino acids
|
|
|
|
|
|
B02AA01
|
Aminocaproic acid
|
|
|
|
|
|
B02AA02
|
Tranexamic acid
|
|
|
|
|
|
B02AA03
|
Aminomethylbenzoic acid
|
|
|
|
|
B02AB
|
|
Proteinase inhibitors
|
|
|
|
|
|
B02AB01
|
Aprotinin
|
|
|
|
|
|
B02AB02
|
Alfa1 antitrypsin
|
|
|
|
|
|
B02AB04
|
Camostat
|
|
|
|
B02B
|
|
|
Vitamin K and other hemostatics
|
|
|
|
|
B02BA
|
|
Vitamin K
|
|
|
|
|
|
B02BA01
|
Phytomenadione
|
|
|
|
|
|
B02BA02
|
Menadione
|
|
|
|
|
B02BB
|
|
Fibrinogen
|
|
|
|
|
|
B02BB01
|
Human fibrinogen
|
|
|
|
|
B02BC
|
|
Local hemostatics
|
|
|
|
|
|
B02BC01
|
Absorbable gelatin sponge
|
|
|
|
|
|
B02BC02
|
Oxidized cellulose
|
|
|
|
|
|
B02BC03
|
Tetragalacturonic acid hydroxymethylester
|
|
|
|
|
|
B02BC05
|
Adrenalone
|
|
|
|
|
|
B02BC06
|
Thrombin
|
|
|
|
|
|
B02BC07
|
Collagen
|
|
|
|
|
|
B02BC08
|
Calcium alginate
|
|
|
|
|
|
B02BC09
|
Epinephrine
|
|
|
|
|
|
B02BC10
|
Fibrinogen, human
|
|
|
|
|
|
B02BC30
|
Combinations
|
|
|
|
|
B02BD
|
|
Blood coagulation factors
|
|
|
|
|
|
B02BD01
|
Coagulation factor IX, II, VII and X in combination (Prothrombin complex concentrate)
|
|
|
|
|
|
B02BD02
|
Coagulation factor VIII
|
|
|
|
|
|
B02BD03
|
Factor VIII inhibitor bypassing activity
|
|
|
|
|
|
B02BD04
|
Coagulation factor IX
|
|
|
|
|
|
B02BD05
|
Coagulation factor VII
|
|
|
|
|
|
B02BD06
|
Von Willebrand factor and coagulation factor VIII in combination
|
|
|
|
|
|
B02BD07
|
Coagulation factor XIII
|
|
|
|
|
|
B02BD08
|
Eptacog alfa (activated)
|
|
|
|
|
|
B02BD09
|
Nonacog alfa
|
|
|
|
|
|
B02BD10
|
von Willebrand factor
|
|
|
|
|
|
B02BD11
|
Catridecacog
|
|
|
|
|
|
B02BD12
|
Trenonacog alfa
|
|
|
|
|
|
B02BD30
|
Thrombin
|
|
|
|
|
B02BX
|
|
Other systemic hemostatics
|
|
|
|
|
|
B02BX01
|
Etamsylate
|
|
|
|
|
|
B02BX02
|
Carbazochrome
|
|
|
|
|
|
B02BX03
|
Batroxobin
|
|
|
|
|
|
B02BX04
|
Romiplostim
|
|
|
|
|
|
B02BX05
|
Eltrombopag
|
|
|
B03
|
|
|
|
Antianemic preparations
|
|
|
|
B03A
|
|
|
Iron preparations
|
|
|
|
|
B03AA
|
|
Iron bivalent, oral preparations
|
|
|
|
|
|
B03AA01
|
Ferrous glycine sulfate
|
|
|
|
|
|
B03AA02
|
Ferrous fumarate
|
|
|
|
|
|
B03AA03
|
Ferrous gluconate
|
|
|
|
|
|
B03AA04
|
Ferrous carbonate
|
|
|
|
|
|
B03AA05
|
Ferrous chloride
|
|
|
|
|
|
B03AA06
|
Ferrous succinate
|
|
|
|
|
|
B03AA07
|
Ferrous sulfate
|
|
|
|
|
|
B03AA08
|
Ferrous tartrate
|
|
|
|
|
|
B03AA09
|
Ferrous aspartate
|
|
|
|
|
|
B03AA10
|
Ferrous ascorbate
|
|
|
|
|
|
B03AA11
|
Ferrous iodine
|
|
|
|
|
B03AB
|
|
Iron trivalent, oral preparations
|
|
|
|
|
|
B03AB01
|
Ferric sodium citrate
|
|
|
|
|
|
B03AB02
|
Saccharated iron oxide
|
|
|
|
|
|
B03AB03
|
Sodium feredetate
|
|
|
|
|
|
B03AB04
|
Ferric hydroxide
|
|
|
|
|
|
B03AB05
|
Ferric oxide polymaltose complexes
|
|
|
|
|
|
B03AB06
|
Ferric citrate
|
|
|
|
|
|
B03AB07
|
Chondroitin sulfate-iron complex
|
|
|
|
|
|
B03AB08
|
Ferric acetyl transferrin
|
|
|
|
|
|
B03AB09
|
Ferric proteinsuccinylate
|
|
|
|
|
B03AC
|
|
Iron trivalent, parenteral preparations
|
|
|
|
|
|
B03AC01
|
Ferric oxide polymaltose complexes
|
|
|
|
|
|
B03AC02
|
Saccharated iron oxide
|
|
|
|
|
|
B03AC03
|
Iron-sorbitol-citric acid complex
|
|
|
|
|
|
B03AC05
|
Ferric sorbitol gluconic acid complex
|
|
|
|
|
|
B03AC06
|
Ferric oxide dextran complexes
|
|
|
|
|
|
B03AC07
|
Ferric sodium gluconate complex
|
|
|
|
|
B03AD
|
|
Iron in combination with folic acid
|
|
|
|
|
|
B03AD01
|
Ferrous amino acid complex
|
|
|
|
|
|
B03AD02
|
Ferrous fumarate
|
|
|
|
|
|
B03AD03
|
Ferrous sulfate
|
|
|
|
|
|
B03AD04
|
Ferric oxide polymaltose complexes
|
|
|
|
|
B03AE
|
|
Iron in other combinations
|
|
|
|
|
|
B03AE01
|
Iron, vitamin B12 and folic acid
|
|
|
|
|
|
B03AE02
|
Iron, multivitamins and folic acid
|
|
|
|
|
|
B03AE03
|
Iron and multivitamins
|
|
|
|
|
|
B03AE04
|
Iron, multivitamins and minerals
|
|
|
|
|
|
B03AE10
|
Various combinations
|
|
|
|
B03B
|
|
|
Vitamin B12 and folic acid
|
|
|
|
|
B03BA
|
|
Vitamin B12 (cyanocobalamin and analogues)
|
|
|
|
|
|
B03BA01
|
Cyanocobalamin
|
|
|
|
|
|
B03BA02
|
Cyanocobalamin tannin complex
|
|
|
|
|
|
B03BA03
|
Hydroxocobalamin
|
|
|
|
|
|
B03BA04
|
Cobamamide
|
|
|
|
|
|
B03BA05
|
Mecobalamin
|
|
|
|
|
|
B03BA51
|
Cyanocobalamin, combinations
|
|
|
|
|
|
B03BA53
|
Hydroxocobalamin, combinations
|
|
|
|
|
B03BB
|
|
Folic acid and derivatives
|
|
|
|
|
|
B03BB01
|
Folic acid
|
|
|
|
|
|
B03BB51
|
Folic acid, combinations
|
|
|
|
B03X
|
|
|
Other antianemic preparations
|
|
|
|
|
B03XA
|
|
Other antianemic preparations
|
|
|
|
|
|
B03XA01
|
Erythropoietin
|
|
|
|
|
|
B03XA02
|
Darbepoetin alfa
|
|
|
|
|
|
B03XA03
|
Methoxy polyethylene glycol-epoetin beta
|
|
|
|
|
|
B03XA04
|
Peginesatide
|
|
|
B05
|
|
|
|
Blood substitutes and perfusion solutions
|
|
|
|
B05A
|
|
|
Blood and related products
|
|
|
|
|
B05AA
|
|
Blood substitutes and plasma protein fractions
|
|
|
|
|
|
B05AA01
|
Serum albumin
|
|
|
|
|
|
B05AA02
|
Other plasma protein fractions
|
|
|
|
|
|
B05AA03
|
Fluorocarbon blood substitutes
|
|
|
|
|
|
B05AA05
|
Dextran
|
|
|
|
|
|
B05AA06
|
Gelatin agents
|
|
|
|
|
|
B05AA07
|
Hydroxyethylstarch
|
|
|
|
|
|
B05AA08
|
Hemoglobin crosfumaril
|
|
|
|
|
|
B05AA09
|
Hemoglobin raffimer
|
|
|
|
|
|
B05AA10
|
Hemoglobin glutamer (bovine)
|
|
|
|
|
B05AX
|
|
Other blood products
|
|
|
|
|
|
B05AX01
|
Erythrocytes
|
|
|
|
|
|
B05AX02
|
Thrombocytes
|
|
|
|
|
|
B05AX03
|
Blood plasma
|
|
|
|
|
|
B05AX04
|
Stem cells from umbilical cord blood
|
|
|
|
B05B
|
|
|
I.v. solutions
|
|
|
|
|
B05BA
|
|
Solutions for parenteral nutrition
|
|
|
|
|
|
B05BA01
|
Amino acids
|
|
|
|
|
|
B05BA02
|
Fat emulsions
|
|
|
|
|
|
B05BA03
|
Carbohydrates
|
|
|
|
|
|
B05BA04
|
Protein hydrolysates
|
|
|
|
|
|
B05BA10
|
Combinations
|
|
|
|
|
B05BB
|
|
Solutions affecting the electrolyte balance
|
|
|
|
|
|
B05BB01
|
Electrolytes
|
|
|
|
|
|
B05BB02
|
Electrolytes with carbohydrates
|
|
|
|
|
|
B05BB03
|
Trometamol
|
|
|
|
|
|
B05BB04
|
Electrolytes in combination with other drugs
|
|
|
|
|
B05BC
|
|
Solutions producing osmotic diuresis
|
|
|
|
|
|
B05BC01
|
Mannitol
|
|
|
|
|
|
B05BC02
|
Carbamide
|
|
|
|
B05C
|
|
|
Irrigating solutions
|
|
|
|
|
B05CA
|
|
Antiinfectives
|
|
|
|
|
|
B05CA01
|
Cetylpyridinium
|
|
|
|
|
|
B05CA02
|
Chlorhexidine
|
|
|
|
|
|
B05CA03
|
Nitrofural
|
|
|
|
|
|
B05CA04
|
Sulfamethizole
|
|
|
|
|
|
B05CA05
|
Taurolidine
|
|
|
|
|
|
B05CA06
|
Mandelic acid
|
|
|
|
|
|
B05CA07
|
Noxytiolin
|
|
|
|
|
|
B05CA08
|
Ethacridine lactate
|
|
|
|
|
|
B05CA09
|
Neomycin
|
|
|
|
|
|
B05CA10
|
Combinations
|
|
|
|
|
B05CB
|
|
Salt solutions
|
|
|
|
|
|
B05CB01
|
Sodium chloride
|
|
|
|
|
|
B05CB02
|
Sodium citrate
|
|
|
|
|
|
B05CB03
|
Magnesium citrate
|
|
|
|
|
|
B05CB04
|
Sodium bicarbonate
|
|
|
|
|
|
B05CB10
|
Combinations
|
|
|
|
|
B05CX
|
|
Other irrigating solutions
|
|
|
|
|
|
B05CX01
|
Glucose
|
|
|
|
|
|
B05CX02
|
Sorbitol
|
|
|
|
|
|
B05CX03
|
Glycine
|
|
|
|
|
|
B05CX04
|
Mannitol
|
|
|
|
|
|
B05CX10
|
Combinations
|
|
|
|
B05D
|
|
|
Peritoneal dialytics
|
|
|
|
|
B05DA
|
|
Isotonic solutions
|
|
|
|
|
|
|
empty
|
|
|
|
|
B05DB
|
|
Hypertonic solutions
|
|
|
|
|
|
|
empty
|
|
|
|
B05X
|
|
|
I.v. solution additives
|
|
|
|
|
B05XA
|
|
Electrolyte solutions
|
|
|
|
|
|
B05XA01
|
Potassium chloride
|
|
|
|
|
|
B05XA02
|
Sodium bicarbonate
|
|
|
|
|
|
B05XA03
|
Sodium chloride
|
|
|
|
|
|
B05XA04
|
Ammonium chloride
|
|
|
|
|
|
B05XA05
|
Magnesium sulfate
|
|
|
|
|
|
B05XA06
|
Potassium phosphate, including combinations with other potassium salts
|
|
|
|
|
|
B05XA07
|
Calcium chloride
|
|
|
|
|
|
B05XA08
|
Sodium acetate
|
|
|
|
|
|
B05XA09
|
Sodium phosphate
|
|
|
|
|
|
B05XA10
|
Magnesium phosphate
|
|
|
|
|
|
B05XA11
|
Magnesium chloride
|
|
|
|
|
|
B05XA12
|
Zinc chloride
|
|
|
|
|
|
B05XA13
|
Hydrochloric acid
|
|
|
|
|
|
B05XA14
|
Sodium glycerophosphate
|
|
|
|
|
|
B05XA15
|
Potassium lactate
|
|
|
|
|
|
B05XA16
|
Cardioplegia solutions
|
|
|
|
|
|
B05XA17
|
Potassium acetate
|
|
|
|
|
|
B05XA30
|
Combinations of electrolytes
|
|
|
|
|
|
B05XA31
|
Electrolytes in combination with other drugs
|
|
|
|
|
B05XB
|
|
Amino acids
|
|
|
|
|
|
B05XB01
|
Arginine hydrochloride
|
|
|
|
|
|
B05XB02
|
Alanyl glutamine
|
|
|
|
|
|
B05XB03
|
Lysine
|
|
|
|
|
B05XC
|
|
Vitamins
|
|
|
|
|
|
|
empty
|
|
|
|
|
B05XX
|
|
Other i.v. solution additives
|
|
|
|
|
|
B05XX02
|
Trometamol
|
|
|
|
B05Z
|
|
|
Hemodialytics and hemofiltrates
|
|
|
|
|
B05ZA
|
|
Hemodialytics, concentrates
|
|
|
|
|
|
|
empty
|
|
|
|
|
B05ZB
|
|
Hemofiltrates
|
|
|
|
|
|
|
empty
|
|
|
B06
|
|
|
|
Other hematological agents
|
|
|
|
B06A
|
|
|
Other hematological agents
|
|
|
|
|
B06AA
|
|
Enzymes
|
|
|
|
|
|
B06AA02
|
Fibrinolysin and desoxyribonuclease
|
|
|
|
|
|
B06AA03
|
Hyaluronidase
|
|
|
|
|
|
B06AA04
|
Chymotrypsin
|
|
|
|
|
|
B06AA07
|
Trypsin
|
|
|
|
|
|
B06AA10
|
Desoxyribonuclease
|
|
|
|
|
|
B06AA11
|
Bromelain
|
|
|
|
|
|
B06AA55
|
Streptokinase, combinations
|
|
|
|
|
B06AB
|
|
Other hematological products
|
|
|
|
|
|
B06AB01
|
Hematin
|
|
|
|
|
B06AC
|
|
Drugs used in hereditary angioedema
|
|
|
|
|
|
B06AC01
|
C1-inhibitor, plasma derived
|
|
|
|
|
|
B06AC02
|
Icatibant
|
|
|
|
|
|
B06AC03
|
Ecallantide
|
|
|
|
|
|
B06AC04
|
Conestat alfa
|
| C
|
|
|
|
|
Cardiovascular system
|
|
|
C01
|
|
|
|
Cardiac therapy
|
|
|
|
C01A
|
|
|
Cardiac glycosides
|
|
|
|
|
C01AA
|
|
Digitalis glycosides
|
|
|
|
|
|
C01AA01
|
Acetyldigitoxin
|
|
|
|
|
|
C01AA02
|
Acetyldigoxin
|
|
|
|
|
|
C01AA03
|
Digitalis leaves
|
|
|
|
|
|
C01AA04
|
Digitoxin
|
|
|
|
|
|
C01AA05
|
Digoxin
|
|
|
|
|
|
C01AA06
|
Lanatoside C
|
|
|
|
|
|
C01AA07
|
Deslanoside
|
|
|
|
|
|
C01AA08
|
Metildigoxin
|
|
|
|
|
|
C01AA09
|
Gitoformate
|
|
|
|
|
|
C01AA52
|
Acetyldigoxin, combinations
|
|
|
|
|
C01AB
|
|
Scilla glycosides
|
|
|
|
|
|
C01AB01
|
Proscillaridin
|
|
|
|
|
|
C01AB51
|
Proscillaridin, combinations
|
|
|
|
|
C01AC
|
|
Strophantus glycosides
|
|
|
|
|
|
C01AC01
|
G-strophanthin
|
|
|
|
|
|
C01AC03
|
Cymarin
|
|
|
|
|
C01AX
|
|
Other cardiac glycosides
|
|
|
|
|
|
C01AX02
|
Peruvoside
|
|
|
|
C01B
|
|
|
Antiarrhythmics, class I and III
|
|
|
|
|
C01BA
|
|
Antiarrhythmics, class Ia
|
|
|
|
|
|
C01BA01
|
Quinidine
|
|
|
|
|
|
C01BA02
|
Procainamide
|
|
|
|
|
|
C01BA03
|
Disopyramide
|
|
|
|
|
|
C01BA04
|
Sparteine
|
|
|
|
|
|
C01BA05
|
Ajmaline
|
|
|
|
|
|
C01BA08
|
Prajmaline
|
|
|
|
|
|
C01BA12
|
Lorajmine
|
|
|
|
|
|
C01BA51
|
Quinidine, combinations excluding psycholeptics
|
|
|
|
|
|
C01BA71
|
Quinidine, combinations with psycholeptics
|
|
|
|
|
C01BB
|
|
Antiarrhythmics, class Ib
|
|
|
|
|
|
C01BB01
|
Lidocaine
|
|
|
|
|
|
C01BB02
|
Mexiletine
|
|
|
|
|
|
C01BB03
|
Tocainide
|
|
|
|
|
|
C01BB04
|
Aprindine
|
|
|
|
|
C01BC
|
|
Antiarrhythmics, class Ic
|
|
|
|
|
|
C01BC03
|
Propafenone
|
|
|
|
|
|
C01BC04
|
Flecainide
|
|
|
|
|
|
C01BC07
|
Lorcainide
|
|
|
|
|
|
C01BC08
|
Encainide
|
|
|
|
|
|
C01BC09
|
Ethacizine
|
|
|
|
|
C01BD
|
|
Antiarrhythmics, class III
|
|
|
|
|
|
C01BD01
|
Amiodarone
|
|
|
|
|
|
C01BD02
|
Bretylium tosilate
|
|
|
|
|
|
C01BD03
|
Bunaftine
|
|
|
|
|
|
C01BD04
|
Dofetilide
|
|
|
|
|
|
C01BD05
|
Ibutilide
|
|
|
|
|
|
C01BD06
|
Tedisamil
|
|
|
|
|
|
C01BD07
|
Dronedarone
|
|
|
|
|
C01BG
|
|
Other antiarrhythmics, class I and III
|
|
|
|
|
|
C01BG01
|
Moracizine
|
|
|
|
|
|
C01BG07
|
Cibenzoline
|
|
|
|
|
|
C01BG11
|
Vernakalant
|
|
|
|
C01C
|
|
|
Cardiac stimulants excluding cardiac glycosides
|
|
|
|
|
C01CA
|
|
Adrenergic and dopaminergic agents
|
|
|
|
|
|
C01CA01
|
Etilefrine
|
|
|
|
|
|
C01CA02
|
Isoprenaline
|
|
|
|
|
|
C01CA03
|
Norepinephrine
|
|
|
|
|
|
C01CA04
|
Dopamine
|
|
|
|
|
|
C01CA05
|
Norfenefrine
|
|
|
|
|
|
C01CA06
|
Phenylephrine
|
|
|
|
|
|
C01CA07
|
Dobutamine
|
|
|
|
|
|
C01CA08
|
Oxedrine
|
|
|
|
|
|
C01CA09
|
Metaraminol
|
|
|
|
|
|
C01CA10
|
Methoxamine
|
|
|
|
|
|
C01CA11
|
Mephentermine
|
|
|
|
|
|
C01CA12
|
Dimetofrine
|
|
|
|
|
|
C01CA13
|
Prenalterol
|
|
|
|
|
|
C01CA14
|
Dopexamine
|
|
|
|
|
|
C01CA15
|
Gepefrine
|
|
|
|
|
|
C01CA16
|
Ibopamine
|
|
|
|
|
|
C01CA17
|
Midodrine
|
|
|
|
|
|
C01CA18
|
Octopamine
|
|
|
|
|
|
C01CA19
|
Fenoldopam
|
|
|
|
|
|
C01CA21
|
Cafedrine
|
|
|
|
|
|
C01CA22
|
Arbutamine
|
|
|
|
|
|
C01CA23
|
Theodrenaline
|
|
|
|
|
|
C01CA24
|
Epinephrine
|
|
|
|
|
|
C01CA25
|
Amezinium metilsulfate
|
|
|
|
|
|
C01CA26
|
Ephedrine
|
|
|
|
|
|
C01CA30
|
Combinations
|
|
|
|
|
|
C01CA51
|
Etilefrine, combinations
|
|
|
|
|
C01CE
|
|
Phosphodiesterase inhibitors
|
|
|
|
|
|
C01CE01
|
Amrinone
|
|
|
|
|
|
C01CE02
|
Milrinone
|
|
|
|
|
|
C01CE03
|
Enoximone
|
|
|
|
|
|
C01CE04
|
Bucladesine
|
|
|
|
|
C01CX
|
|
Other cardiac stimulants
|
|
|
|
|
|
C01CX06
|
Angiotensinamide
|
|
|
|
|
|
C01CX07
|
Xamoterol
|
|
|
|
|
|
C01CX08
|
Levosimendan
|
|
|
|
C01D
|
|
|
Vasodilators used in cardiac diseases
|
|
|
|
|
C01DA
|
|
Organic nitrates
|
|
|
|
|
|
C01DA02
|
Glyceryl trinitrate
|
|
|
|
|
|
C01DA04
|
Methylpropylpropanediol dinitrate
|
|
|
|
|
|
C01DA05
|
Pentaerithrityl tetranitrate
|
|
|
|
|
|
C01DA07
|
Propatylnitrate
|
|
|
|
|
|
C01DA08
|
Isosorbide dinitrate
|
|
|
|
|
|
C01DA09
|
Trolnitrate
|
|
|
|
|
|
C01DA13
|
Eritrityl tetranitrate
|
|
|
|
|
|
C01DA14
|
Isosorbide mononitrate
|
|
|
|
|
|
C01DA20
|
Organic nitrates in combination
|
|
|
|
|
|
C01DA38
|
Tenitramine
|
|
|
|
|
|
C01DA52
|
Glyceryl trinitrate, combinations
|
|
|
|
|
|
C01DA54
|
Methylpropylpropanediol dinitrate, combinations
|
|
|
|
|
|
C01DA55
|
Pentaerithrityl tetranitrate, combinations
|
|
|
|
|
|
C01DA57
|
Propatylnitrate, combinations
|
|
|
|
|
|
C01DA58
|
Isosorbide dinitrate, combinations
|
|
|
|
|
|
C01DA59
|
Trolnitrate, combinations
|
|
|
|
|
|
C01DA63
|
Eritrityl tetranitrate, combinations
|
|
|
|
|
|
C01DA70
|
Organic nitrates in combination with psycholeptics
|
|
|
|
|
C01DB
|
|
Quinolone vasodilators
|
|
|
|
|
|
C01DB01
|
Flosequinan
|
|
|
|
|
C01DX
|
|
Other vasodilators used in cardiac diseases
|
|
|
|
|
|
C01DX01
|
Itramin tosilate
|
|
|
|
|
|
C01DX02
|
Prenylamine
|
|
|
|
|
|
C01DX03
|
Oxyfedrine
|
|
|
|
|
|
C01DX04
|
Benziodarone
|
|
|
|
|
|
C01DX05
|
Carbocromen
|
|
|
|
|
|
C01DX06
|
Hexobendine
|
|
|
|
|
|
C01DX07
|
Etafenone
|
|
|
|
|
|
C01DX08
|
Heptaminol
|
|
|
|
|
|
C01DX09
|
Imolamine
|
|
|
|
|
|
C01DX10
|
Dilazep
|
|
|
|
|
|
C01DX11
|
Trapidil
|
|
|
|
|
|
C01DX12
|
Molsidomine
|
|
|
|
|
|
C01DX13
|
Efloxate
|
|
|
|
|
|
C01DX14
|
Cinepazet
|
|
|
|
|
|
C01DX15
|
Cloridarol
|
|
|
|
|
|
C01DX16
|
Nicorandil
|
|
|
|
|
|
C01DX18
|
Linsidomine
|
|
|
|
|
|
C01DX19
|
Nesiritide
|
|
|
|
|
|
C01DX51
|
Itramin tosilate, combinations
|
|
|
|
|
|
C01DX52
|
Prenylamine, combinations
|
|
|
|
|
|
C01DX53
|
Oxyfedrine, combinations
|
|
|
|
|
|
C01DX54
|
Benziodarone, combinations
|
|
|
|
C01E
|
|
|
Other cardiac preparations
|
|
|
|
|
C01EA
|
|
Prostaglandins
|
|
|
|
|
|
C01EA01
|
Alprostadil
|
|
|
|
|
C01EB
|
|
Other cardiac preparations
|
|
|
|
|
|
C01EB02
|
Camphor
|
|
|
|
|
|
C01EB03
|
Indometacin
|
|
|
|
|
|
C01EB04
|
Crataegus glycosides
|
|
|
|
|
|
C01EB05
|
Creatinolfosfate
|
|
|
|
|
|
C01EB06
|
Fosfocreatine
|
|
|
|
|
|
C01EB07
|
Fructose 1,6-diphosphate
|
|
|
|
|
|
C01EB09
|
Ubidecarenone
|
|
|
|
|
|
C01EB10
|
Adenosine
|
|
|
|
|
|
C01EB11
|
Tiracizine
|
|
|
|
|
|
C01EB13
|
Acadesine
|
|
|
|
|
|
C01EB15
|
Trimetazidine
|
|
|
|
|
|
C01EB16
|
Ibuprofen
|
|
|
|
|
|
C01EB17
|
Ivabradine
|
|
|
|
|
|
C01EB18
|
Ranolazine
|
|
|
|
|
|
C01EB21
|
Regadenoson
|
|
|
|
|
C01EX
|
|
Other cardiac combination products
|
|
|
|
|
|
|
empty
|
|
|
C02
|
|
|
|
Antihypertensives
|
|
|
|
C02A
|
|
|
Antiadrenergic agents, centrally acting
|
|
|
|
|
C02AA
|
|
Rauvolfia alkaloids
|
|
|
|
|
|
C02AA01
|
Rescinnamine
|
|
|
|
|
|
C02AA02
|
Reserpine
|
|
|
|
|
|
C02AA03
|
Combinations of rauwolfia alkaloids
|
|
|
|
|
|
C02AA04
|
Rauwolfia alkaloids, whole root
|
|
|
|
|
|
C02AA05
|
Deserpidine
|
|
|
|
|
|
C02AA06
|
Methoserpidine
|
|
|
|
|
|
C02AA07
|
Bietaserpine
|
|
|
|
|
|
C02AA52
|
Reserpine, combinations
|
|
|
|
|
|
C02AA53
|
Combinations of rauwolfia alkoloids, combinations
|
|
|
|
|
|
C02AA57
|
Bietaserpine, combinations
|
|
|
|
|
C02AB
|
|
Methyldopa
|
|
|
|
|
|
C02AB01
|
Methyldopa (levorotatory)
|
|
|
|
|
|
C02AB02
|
Methyldopa (racemic)
|
|
|
|
|
C02AC
|
|
Imidazoline receptor agonists
|
|
|
|
|
|
C02AC01
|
Clonidine
|
|
|
|
|
|
C02AC02
|
Guanfacine
|
|
|
|
|
|
C02AC04
|
Tolonidine
|
|
|
|
|
|
C02AC05
|
Moxonidine
|
|
|
|
|
|
C02AC06
|
Rilmenidine
|
|
|
|
C02B
|
|
|
Antiadrenergic agents, ganglion-blocking
|
|
|
|
|
C02BA
|
|
Sulfonium derivatives
|
|
|
|
|
|
C02BA01
|
Trimetaphan
|
|
|
|
|
C02BB
|
|
Secondary and tertiary amines
|
|
|
|
|
|
C02BB01
|
Mecamylamine
|
|
|
|
|
C02BC
|
|
Bisquaternary ammonium compounds
|
|
|
|
|
|
|
empty
|
|
|
|
C02C
|
|
|
Antiadrenergic agents, peripherally acting
|
|
|
|
|
C02CA
|
|
Alpha-adrenoreceptor antagonists
|
|
|
|
|
|
C02CA01
|
Prazosin
|
|
|
|
|
|
C02CA02
|
Indoramin
|
|
|
|
|
|
C02CA03
|
Trimazosin
|
|
|
|
|
|
C02CA04
|
Doxazosin
|
|
|
|
|
|
C02CA06
|
Urapidil
|
|
|
|
|
C02CC
|
|
Guanidine derivatives
|
|
|
|
|
|
C02CC01
|
Betanidine
|
|
|
|
|
|
C02CC02
|
Guanethidine
|
|
|
|
|
|
C02CC03
|
Guanoxan
|
|
|
|
|
|
C02CC04
|
Debrisoquine
|
|
|
|
|
|
C02CC05
|
Guanoclor
|
|
|
|
|
|
C02CC06
|
Guanazodine
|
|
|
|
|
|
C02CC07
|
Guanoxabenz
|
|
|
|
C02D
|
|
|
Arteriolar smooth muscle, agents acting on
|
|
|
|
|
C02DA
|
|
Thiazide derivatives
|
|
|
|
|
|
C02DA01
|
Diazoxide
|
|
|
|
|
C02DB
|
|
Hydrazinophthalazine derivatives
|
|
|
|
|
|
C02DB01
|
Dihydralazine
|
|
|
|
|
|
C02DB02
|
Hydralazine
|
|
|
|
|
|
C02DB03
|
Endralazine
|
|
|
|
|
|
C02DB04
|
Cadralazine
|
|
|
|
|
C02DC
|
|
Pyrimidine derivatives
|
|
|
|
|
|
C02DC01
|
Minoxidil
|
|
|
|
|
C02DD
|
|
Nitroferricyanide derivatives
|
|
|
|
|
|
C02DD01
|
Nitroprusside
|
|
|
|
|
C02DG
|
|
Guanidine derivatives
|
|
|
|
|
|
C02DG01
|
Pinacidil
|
|
|
|
C02K
|
|
|
Other antihypertensives
|
|
|
|
|
C02KA
|
|
Alkaloids, excluding rauwolfia
|
|
|
|
|
|
C02KA01
|
Veratrum
|
|
|
|
|
C02KB
|
|
Tyrosine hydroxylase inhibitors
|
|
|
|
|
|
C02KB01
|
Metirosine
|
|
|
|
|
C02KC
|
|
MAO inhibitors
|
|
|
|
|
|
C02KC01
|
Pargyline
|
|
|
|
|
C02KD
|
|
Serotonin antagonists
|
|
|
|
|
|
C02KD01
|
Ketanserin
|
|
|
|
|
C02KX
|
|
Other antihypertensives
|
|
|
|
|
|
C02KX01
|
Bosentan
|
|
|
|
|
|
C02KX02
|
Ambrisentan
|
|
|
|
|
|
C02KX03
|
Sitaxentan
|
|
|
|
C02L
|
|
|
Antihypertensives and diuretics in combination
|
|
|
|
|
C02LA
|
|
Rauwolfia alkaloids and diuretics in combination
|
|
|
|
|
|
C02LA01
|
Reserpine and diuretics
|
|
|
|
|
|
C02LA02
|
Rescinnamine and diuretics
|
|
|
|
|
|
C02LA03
|
Deserpidine and diuretics
|
|
|
|
|
|
C02LA04
|
Methoserpidine and diuretics
|
|
|
|
|
|
C02LA07
|
Bietaserpine and diuretics
|
|
|
|
|
|
C02LA08
|
Rauwolfia alkaloids, whole root and diuretics
|
|
|
|
|
|
C02LA09
|
Syrosingopine and diuretics
|
|
|
|
|
|
C02LA50
|
Combinations of rauwolfia alkaloids and diuretics including other combinations
|
|
|
|
|
|
C02LA51
|
Reserpine and diuretics, combinations with other drugs
|
|
|
|
|
|
C02LA52
|
Rescinnamine and diuretics, combinations with other drugs
|
|
|
|
|
|
C02LA71
|
Reserpine and diuretics, combinations with psycholeptics
|
|
|
|
|
C02LB
|
|
Methyldopa and diuretics in combination
|
|
|
|
|
|
C02LB01
|
Methyldopa (levorotatory) and diuretics
|
|
|
|
|
C02LC
|
|
Imidazoline receptor agonists in combination with diuretics
|
|
|
|
|
|
C02LC01
|
Clonidine and diuretics
|
|
|
|
|
|
C02LC05
|
Moxonidine and diuretics
|
|
|
|
|
|
C02LC51
|
Clonidine and diuretics, combinations with other drugs
|
|
|
|
|
C02LE
|
|
Alpha-adrenoreceptor antagonists and diuretics
|
|
|
|
|
|
C02LE01
|
Prazosin and diuretics
|
|
|
|
|
C02LF
|
|
Guanidine derivatives and diuretics
|
|
|
|
|
|
C02LF01
|
Guanethidine and diuretics
|
|
|
|
|
C02LG
|
|
Hydrazinophthalazine derivatives and diuretics
|
|
|
|
|
|
C02LG01
|
Dihydralazine and diuretics
|
|
|
|
|
|
C02LG02
|
Hydralazine and diuretics
|
|
|
|
|
|
C02LG03
|
Picodralazine and diuretics
|
|
|
|
|
|
C02LG51
|
Dihydralazine and diuretics, combinations with other drugs
|
|
|
|
|
|
C02LG73
|
Picodralazine and diuretics, combinations with psycholeptics
|
|
|
|
|
C02LK
|
|
Alkaloids, excluding rauwolfia, in combination with diuretics
|
|
|
|
|
|
C02LK01
|
Veratrum and diuretics
|
|
|
|
|
C02LL
|
|
MAO inhibitors and diuretics
|
|
|
|
|
|
C02LL01
|
Pargyline and diuretics
|
|
|
|
C02LN
|
|
|
Serotonin antagonists and diuretics
|
|
|
|
|
|
|
empty
|
|
|
|
C02LX
|
|
|
Other antihypertensives and diuretics
|
|
|
|
|
|
C02LX01
|
Pinacidil and diuretics
|
|
|
|
C02N
|
|
|
Combinations of antihypertensives in ATC-group C02
|
|
|
|
|
|
|
empty
|
|
|
C03
|
|
|
|
Diuretics
|
|
|
|
C03A
|
|
|
Low-ceiling diuretics, thiazides
|
|
|
|
|
C03AA
|
|
Thiazides, plain
|
|
|
|
|
|
C03AA01
|
Bendroflumethiazide
|
|
|
|
|
|
C03AA02
|
Hydroflumethiazide
|
|
|
|
|
|
C03AA03
|
Hydrochlorothiazide
|
|
|
|
|
|
C03AA04
|
Chlorothiazide
|
|
|
|
|
|
C03AA05
|
Polythiazide
|
|
|
|
|
|
C03AA06
|
Trichlormethiazide
|
|
|
|
|
|
C03AA07
|
Cyclopenthiazide
|
|
|
|
|
|
C03AA08
|
Methyclothiazide
|
|
|
|
|
|
C03AA09
|
Cyclothiazide
|
|
|
|
|
|
C03AA13
|
Mebutizide
|
|
|
|
|
C03AB
|
|
Thiazides and potassium in combination
|
|
|
|
|
|
C03AB01
|
Bendroflumethiazide and potassium
|
|
|
|
|
|
C03AB02
|
Hydroflumethiazide and potassium
|
|
|
|
|
|
C03AB03
|
Hydrochlorothiazide and potassium
|
|
|
|
|
|
C03AB04
|
Chlorothiazide and potassium
|
|
|
|
|
|
C03AB05
|
Polythiazide and potassium
|
|
|
|
|
|
C03AB06
|
Trichlormethiazide and potassium
|
|
|
|
|
|
C03AB07
|
Cyclopenthiazide and potassium
|
|
|
|
|
|
C03AB08
|
Methyclothiazide and potassium
|
|
|
|
|
|
C03AB09
|
Cyclothiazide and potassium
|
|
|
|
|
C03AH
|
|
Thiazides, combinations with psycholeptics and/or analgesics
|
|
|
|
|
|
C03AH01
|
Chlorothiazide, combinations
|
|
|
|
|
|
C03AH02
|
Hydroflumethiazide, combinations
|
|
|
|
|
C03AX
|
|
Thiazides, combinations with other drugs
|
|
|
|
|
|
C03AX01
|
Hydrochlorothiazide, combinations
|
|
|
|
C03B
|
|
|
Low-ceiling diuretics, excluding thiazides
|
|
|
|
|
C03BA
|
|
Sulfonamides, plain
|
|
|
|
|
|
C03BA02
|
Quinethazone
|
|
|
|
|
|
C03BA03
|
Clopamide
|
|
|
|
|
|
C03BA04
|
Chlortalidone
|
|
|
|
|
|
C03BA05
|
Mefruside
|
|
|
|
|
|
C03BA07
|
Clofenamide
|
|
|
|
|
|
C03BA08
|
Metolazone
|
|
|
|
|
|
C03BA09
|
Meticrane
|
|
|
|
|
|
C03BA10
|
Xipamide
|
|
|
|
|
|
C03BA11
|
Indapamide
|
|
|
|
|
|
C03BA12
|
Clorexolone
|
|
|
|
|
|
C03BA13
|
Fenquizone
|
|
|
|
|
|
C03BA82
|
Clorexolone, combinations with psycholeptics
|
|
|
|
|
C03BB
|
|
Sulfonamides and potassium in combination
|
|
|
|
|
|
C03BB02
|
Quinethazone and potassium
|
|
|
|
|
|
C03BB03
|
Clopamide and potassium
|
|
|
|
|
|
C03BB04
|
Chlortalidone and potassium
|
|
|
|
|
|
C03BB05
|
Mefruside and potassium
|
|
|
|
|
|
C03BB07
|
Clofenamide and potassium
|
|
|
|
|
C03BC
|
|
Mercurial diuretics
|
|
|
|
|
|
C03BC01
|
Mersalyl
|
|
|
|
|
C03BD
|
|
Xanthine derivatives
|
|
|
|
|
|
C03BD01
|
Theobromine
|
|
|
|
|
C03BK
|
|
Sulfonamides, combinations with other drugs
|
|
|
|
|
|
|
empty
|
|
|
|
|
C03BX
|
|
Other low-ceiling diuretics
|
|
|
|
|
|
C03BX03
|
Cicletanine
|
|
|
|
C03C
|
|
|
High-ceiling diuretics
|
|
|
|
|
C03CA
|
|
Sulfonamides, plain
|
|
|
|
|
|
C03CA01
|
Furosemide
|
|
|
|
|
|
C03CA02
|
Bumetanide
|
|
|
|
|
|
C03CA03
|
Piretanide
|
|
|
|
|
|
C03CA04
|
Torasemide
|
|
|
|
|
C03CB
|
|
Sulfonamides and potassium in combination
|
|
|
|
|
|
C03CB01
|
Furosemide and potassium
|
|
|
|
|
|
C03CB02
|
Bumetanide and potassium
|
|
|
|
|
C03CC
|
|
Aryloxyacetic acid derivatives
|
|
|
|
|
|
C03CC01
|
Etacrynic acid
|
|
|
|
|
|
C03CC02
|
Tienilic acid
|
|
|
|
|
C03CD
|
|
Pyrazolone derivatives
|
|
|
|
|
|
C03CD01
|
Muzolimine
|
|
|
|
|
C03CX
|
|
Other high-ceiling diuretics
|
|
|
|
|
|
C03CX01
|
Etozolin
|
|
|
|
C03D
|
|
|
Potassium-sparing agents
|
|
|
|
|
C03DA
|
|
Aldosterone antagonists
|
|
|
|
|
|
C03DA01
|
Spironolactone
|
|
|
|
|
|
C03DA02
|
Potassium canrenoate
|
|
|
|
|
|
C03DA03
|
Canrenone
|
|
|
|
|
|
C03DA04
|
Eplerenone
|
|
|
|
|
C03DB
|
|
Other potassium-sparing agents
|
|
|
|
|
|
C03DB01
|
Amiloride
|
|
|
|
|
|
C03DB02
|
Triamterene
|
|
|
|
C03E
|
|
|
Diuretics and potassium-sparing agents in combination
|
|
|
|
|
C03EA
|
|
Low-ceiling diuretics and potassium-sparing agents
|
|
|
|
|
|
C03EA01
|
Hydrochlorothiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA02
|
Trichlormethiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA03
|
Epitizide and potassium-sparing agents
|
|
|
|
|
|
C03EA04
|
Altizide and potassium-sparing agents
|
|
|
|
|
|
C03EA05
|
Mebutizide and potassium-sparing agents
|
|
|
|
|
|
C03EA06
|
Chlortalidone and potassium-sparing agents
|
|
|
|
|
|
C03EA07
|
Cyclopenthiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA12
|
Metolazone and potassium-sparing agents
|
|
|
|
|
|
C03EA13
|
Bendroflumethiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA14
|
Butizide and potassium-sparing agents
|
|
|
|
|
C03EB
|
|
High-ceiling diuretics and potassium-sparing agents
|
|
|
|
|
|
C03EB01
|
Furosemide and potassium-sparing agents
|
|
|
|
|
|
C03EB02
|
Bumetanide and potassium-sparing agents
|
|
|
|
C03X
|
|
|
Other diuretics
|
|
|
|
|
C03XA
|
|
Vasopressin antagonists
|
|
|
|
|
|
C03XA01
|
Tolvaptan
|
|
|
|
|
|
C03XA02
|
Conivaptan
|
|
|
C04
|
|
|
|
Peripheral vasodilators
|
|
|
|
C04A
|
|
|
Peripheral vasodilators
|
|
|
|
|
C04AA
|
|
2-amino-1-phenylethanol derivatives
|
|
|
|
|
|
C04AA01
|
Isoxsuprine
|
|
|
|
|
|
C04AA02
|
Buphenine
|
|
|
|
|
|
C04AA31
|
Bamethan
|
|
|
|
|
C04AB
|
|
Imidazoline derivatives
|
|
|
|
|
|
C04AB01
|
Phentolamine
|
|
|
|
|
|
C04AB02
|
Tolazoline
|
|
|
|
|
C04AC
|
|
Nicotinic acid and derivatives
|
|
|
|
|
|
C04AC01
|
Nicotinic acid
|
|
|
|
|
|
C04AC02
|
Nicotinyl alcohol (pyridylcarbinol)
|
|
|
|
|
|
C04AC03
|
Inositol nicotinate
|
|
|
|
|
|
C04AC07
|
Ciclonicate
|
|
|
|
|
C04AD
|
|
Purine derivatives
|
|
|
|
|
|
C04AD01
|
Pentifylline
|
|
|
|
|
|
C04AD02
|
Xantinol nicotinate
|
|
|
|
|
|
C04AD03
|
Pentoxifylline
|
|
|
|
|
|
C04AD04
|
Etofylline nicotinate
|
|
|
|
|
C04AE
|
|
Ergot alkaloids
|
|
|
|
|
|
C04AE01
|
Ergoloid mesylates
|
|
|
|
|
|
C04AE02
|
Nicergoline
|
|
|
|
|
|
C04AE04
|
Dihydroergocristine
|
|
|
|
|
|
C04AE51
|
Ergoloid mesylates, combinations
|
|
|
|
|
|
C04AE54
|
Dihydroergocristine, combinations
|
|
|
|
|
C04AF
|
|
Enzymes
|
|
|
|
|
|
C04AF01
|
Kallidinogenase
|
|
|
|
|
C04AX
|
|
Other peripheral vasodilators
|
|
|
|
|
|
C04AX01
|
Cyclandelate
|
|
|
|
|
|
C04AX02
|
Phenoxybenzamine
|
|
|
|
|
|
C04AX07
|
Vincamine
|
|
|
|
|
|
C04AX10
|
Moxisylyte
|
|
|
|
|
|
C04AX11
|
Bencyclane
|
|
|
|
|
|
C04AX17
|
Vinburnine
|
|
|
|
|
|
C04AX19
|
Sulcotidil
|
|
|
|
|
|
C04AX20
|
Buflomedil
|
|
|
|
|
|
C04AX21
|
Naftidrofuryl
|
|
|
|
|
|
C04AX23
|
Butalamine
|
|
|
|
|
|
C04AX24
|
Visnadine
|
|
|
|
|
|
C04AX26
|
Cetiedil
|
|
|
|
|
|
C04AX27
|
Cinepazide
|
|
|
|
|
|
C04AX28
|
Ifenprodil
|
|
|
|
|
|
C04AX30
|
Azapetine
|
|
|
|
|
|
C04AX32
|
Fasudil
|
|
|
C05
|
|
|
|
Vasoprotectives
|
|
|
|
C05A
|
|
|
Agents for treatment of hemorrhoids and anal fissures for topical use
|
|
|
|
|
C05AA
|
|
Corticosteroids
|
|
|
|
|
|
C05AA01
|
Hydrocortisone
|
|
|
|
|
|
C05AA04
|
Prednisolone
|
|
|
|
|
|
C05AA05
|
Betamethasone
|
|
|
|
|
|
C05AA06
|
Fluorometholone
|
|
|
|
|
|
C05AA08
|
Fluocortolone
|
|
|
|
|
|
C05AA09
|
Dexamethasone
|
|
|
|
|
|
C05AA10
|
Fluocinolone acetonide
|
|
|
|
|
|
C05AA11
|
Fluocinonide
|
|
|
|
|
|
C05AA12
|
Triamcinolone
|
|
|
|
|
C05AB
|
|
Antibiotics
|
|
|
|
|
|
|
empty
|
|
|
|
|
C05AD
|
|
Local anesthetics
|
|
|
|
|
|
C05AD01
|
Lidocaine
|
|
|
|
|
|
C05AD02
|
Tetracaine
|
|
|
|
|
|
C05AD03
|
Benzocaine
|
|
|
|
|
|
C05AD04
|
Cinchocaine
|
|
|
|
|
|
C05AD05
|
Procaine
|
|
|
|
|
|
C05AD06
|
Oxetacaine
|
|
|
|
|
|
C05AD07
|
Pramocaine
|
|
|
|
|
C05AE
|
|
Muscle relaxants
|
|
|
|
|
|
C05AE01
|
Glyceryl trinitrate
|
|
|
|
|
|
C05AE02
|
Isosorbide dinitrate
|
|
|
|
|
C05AX
|
|
Other agents for treatment of hemorrhoids and anal fissures for topical use
|
|
|
|
|
|
C05AX01
|
Aluminium preparations
|
|
|
|
|
|
C05AX02
|
Bismuth preparations, combinations
|
|
|
|
|
|
C05AX03
|
Other preparations, combinations
|
|
|
|
|
|
C05AX04
|
Zinc preparations
|
|
|
|
|
|
C05AX05
|
Tribenoside
|
|
|
|
C05B
|
|
|
Antivaricose therapy
|
|
|
|
|
C05BA
|
|
Heparins or heparinoids for topical use
|
|
|
|
|
|
C05BA01
|
Organo-heparinoid
|
|
|
|
|
|
C05BA02
|
Sodium apolate
|
|
|
|
|
|
C05BA03
|
Heparin
|
|
|
|
|
|
C05BA04
|
Pentosan polysulfate sodium
|
|
|
|
|
|
C05BA51
|
Heparinoid, combinations
|
|
|
|
|
|
C05BA53
|
Heparin, combinations
|
|
|
|
|
C05BB
|
|
Sclerosing agents for local injection
|
|
|
|
|
|
C05BB01
|
Monoethanolamine oleate
|
|
|
|
|
|
C05BB02
|
Polidocanol
|
|
|
|
|
|
C05BB03
|
Invert sugar
|
|
|
|
|
|
C05BB04
|
Sodium tetradecyl sulfate
|
|
|
|
|
|
C05BB05
|
Phenol
|
|
|
|
|
|
C05BB56
|
Glucose, combinations
|
|
|
|
|
C05BX
|
|
Other sclerosing agents
|
|
|
|
|
|
C05BX01
|
Calcium dobesilate
|
|
|
|
|
|
C05BX51
|
Calcium dobesilate, combinations
|
|
|
|
C05C
|
|
|
Capillary stabilising agents
|
|
|
|
|
C05CA
|
|
Bioflavonoids
|
|
|
|
|
|
C05CA01
|
Rutoside
|
|
|
|
|
|
C05CA02
|
Monoxerutin
|
|
|
|
|
|
C05CA03
|
Diosmin
|
|
|
|
|
|
C05CA04
|
Troxerutin
|
|
|
|
|
|
C05CA05
|
Hidrosmin
|
|
|
|
|
|
C05CA51
|
Rutoside, combinations
|
|
|
|
|
|
C05CA53
|
Diosmin, combinations
|
|
|
|
|
|
C05CA54
|
Troxerutin, combinations
|
|
|
|
|
C05CX
|
|
Other capillary stabilising agents
|
|
|
|
|
|
C05CX01
|
Tribenoside
|
|
|
|
|
|
C05CX02
|
Naftazone
|
|
|
|
|
|
C05CX03
|
Hippocastani semen
|
|
|
C07
|
|
|
|
Beta blocking agents
|
|
|
|
C07A
|
|
|
Beta blocking agents
|
|
|
|
|
C07AA
|
|
Beta blocking agents, non-selective
|
|
|
|
|
|
C07AA01
|
Alprenolol
|
|
|
|
|
|
C07AA02
|
Oxprenolol
|
|
|
|
|
|
C07AA03
|
Pindolol
|
|
|
|
|
|
C07AA05
|
Propranolol
|
|
|
|
|
|
C07AA06
|
Timolol
|
|
|
|
|
|
C07AA07
|
Sotalol
|
|
|
|
|
|
C07AA12
|
Nadolol
|
|
|
|
|
|
C07AA14
|
Mepindolol
|
|
|
|
|
|
C07AA15
|
Carteolol
|
|
|
|
|
|
C07AA16
|
Tertatolol
|
|
|
|
|
|
C07AA17
|
Bopindolol
|
|
|
|
|
|
C07AA19
|
Bupranolol
|
|
|
|
|
|
C07AA23
|
Penbutolol
|
|
|
|
|
|
C07AA27
|
Cloranolol
|
|
|
|
|
|
C07AA57
|
Sotalol, combinations
|
|
|
|
|
C07AB
|
|
Beta blocking agents, selective
|
|
|
|
|
|
C07AB01
|
Practolol
|
|
|
|
|
|
C07AB02
|
Metoprolol
|
|
|
|
|
|
C07AB03
|
Atenolol
|
|
|
|
|
|
C07AB04
|
Acebutolol
|
|
|
|
|
|
C07AB05
|
Betaxolol
|
|
|
|
|
|
C07AB06
|
Bevantolol
|
|
|
|
|
|
C07AB07
|
Bisoprolol
|
|
|
|
|
|
C07AB08
|
Celiprolol
|
|
|
|
|
|
C07AB09
|
Esmolol
|
|
|
|
|
|
C07AB10
|
Epanolol
|
|
|
|
|
|
C07AB11
|
S-atenolol
|
|
|
|
|
|
C07AB12
|
Nebivolol
|
|
|
|
|
|
C07AB13
|
Talinolol
|
|
|
|
|
|
C07AB52
|
Metoprolol, combinations
|
|
|
|
|
|
C07AB57
|
Bisoprolol, combinations
|
|
|
|
|
C07AG
|
|
Alpha and beta blocking agents
|
|
|
|
|
|
C07AG01
|
Labetalol
|
|
|
|
|
|
C07AG02
|
Carvedilol
|
|
|
|
C07B
|
|
|
Beta blocking agents and thiazides
|
|
|
|
|
C07BA
|
|
Beta blocking agents, non-selective, and thiazides
|
|
|
|
|
|
C07BA02
|
Oxprenolol and thiazides
|
|
|
|
|
|
C07BA05
|
Propranolol and thiazides
|
|
|
|
|
|
C07BA06
|
Timolol and thiazides
|
|
|
|
|
|
C07BA07
|
Sotalol and thiazides
|
|
|
|
|
|
C07BA12
|
Nadolol and thiazides
|
|
|
|
|
|
C07BA68
|
Metipranolol and thiazides, combinations
|
|
|
|
|
C07BB
|
|
Beta blocking agents, selective, and thiazides
|
|
|
|
|
|
C07BB02
|
Metoprolol and thiazides
|
|
|
|
|
|
C07BB03
|
Atenolol and thiazides
|
|
|
|
|
|
C07BB04
|
Acebutolol and thiazides
|
|
|
|
|
|
C07BB06
|
Bevantolol and thiazides
|
|
|
|
|
|
C07BB07
|
Bisoprolol and thiazides
|
|
|
|
|
|
C07BB12
|
Nebivolol and thiazides
|
|
|
|
|
|
C07BB52
|
Metoprolol and thiazides, combinations
|
|
|
|
|
C07BG
|
|
Alpha and beta blocking agents and thiazides
|
|
|
|
|
|
C07BG01
|
Labetalol and thiazides
|
|
|
|
C07C
|
|
|
Beta blocking agents and other diuretics
|
|
|
|
|
C07CA
|
|
Beta blocking agents, non-selective, and other diuretics
|
|
|
|
|
|
C07CA02
|
Oxprenolol and other diuretics
|
|
|
|
|
|
C07CA03
|
Pindolol and other diuretics
|
|
|
|
|
|
C07CA17
|
Bopindolol and other diuretics
|
|
|
|
|
|
C07CA23
|
Penbutolol and other diuretics
|
|
|
|
|
C07CB
|
|
Beta blocking agents, selective, and other diuretics
|
|
|
|
|
|
C07CB02
|
Metoprolol and other diuretics
|
|
|
|
|
|
C07CB03
|
Atenolol and other diuretics
|
|
|
|
|
|
C07CB53
|
Atenolol and other diuretics, combinations
|
|
|
|
|
C07CG
|
|
Alpha and beta blocking agents and other diuretics
|
|
|
|
|
|
C07CG01
|
Labetalol and other diuretics
|
|
|
|
C07D
|
|
|
Beta blocking agents, thiazides and other diuretics
|
|
|
|
|
C07DA
|
|
Beta blocking agents, non-selective, thiazides and other diuretics
|
|
|
|
|
|
C07DA06
|
Timolol, thiazides and other diuretics
|
|
|
|
|
C07DB
|
|
Beta blocking agents, selective, thiazides and other diuretics
|
|
|
|
|
|
C07DB01
|
Atenolol, thiazides and other diuretics
|
|
|
|
C07E
|
|
|
Beta blocking agents and vasodilators
|
|
|
|
|
C07EA
|
|
Beta blocking agents, non-selective, and vasodilators
|
|
|
|
|
|
|
empty
|
|
|
|
|
C07EB
|
|
Beta blocking agents, selective, and vasodilators
|
|
|
|
|
|
|
empty
|
|
|
|
C07F
|
|
|
Beta blocking agents and other antihypertensives
|
|
|
|
|
C07FA
|
|
Beta blocking agents, non-selective, and other antihypertensives
|
|
|
|
|
|
C07FA05
|
Propranolol and other antihypertensives
|
|
|
|
|
C07FB
|
|
Beta blocking agents, selective, and other antihypertensives
|
|
|
|
|
|
C07FB02
|
Metoprolol and other antihypertensives
|
|
|
|
|
|
C07FB03
|
Atenolol and other antihypertensives
|
|
|
|
|
|
C07FB07
|
Bisoprolol and other antihypertensives
|
|
|
C08
|
|
|
|
Calcium channel blockers
|
|
|
|
C08C
|
|
|
Selective calcium channel blockers with mainly vascular effects
|
|
|
|
|
C08CA
|
|
Dihydropyridine derivatives
|
|
|
|
|
|
C08CA01
|
Amlodipine
|
|
|
|
|
|
C08CA02
|
Felodipine
|
|
|
|
|
|
C08CA03
|
Isradipine
|
|
|
|
|
|
C08CA04
|
Nicardipine
|
|
|
|
|
|
C08CA05
|
Nifedipine
|
|
|
|
|
|
C08CA06
|
Nimodipine
|
|
|
|
|
|
C08CA07
|
Nisoldipine
|
|
|
|
|
|
C08CA08
|
Nitrendipine
|
|
|
|
|
|
C08CA09
|
Lacidipine
|
|
|
|
|
|
C08CA10
|
Nilvadipine
|
|
|
|
|
|
C08CA11
|
Manidipine
|
|
|
|
|
|
C08CA12
|
Barnidipine
|
|
|
|
|
|
C08CA13
|
Lercanidipine
|
|
|
|
|
|
C08CA14
|
Cilnidipine
|
|
|
|
|
|
C08CA15
|
Benidipine
|
|
|
|
|
|
C08CA16
|
Clevidipine
|
|
|
|
|
|
C08CA55
|
Nifedipine, combinations
|
|
|
|
|
C08CX
|
|
Other selective calcium channel blockers with mainly vascular effects
|
|
|
|
|
|
C08CX01
|
Mibefradil
|
|
|
|
C08D
|
|
|
Selective calcium channel blockers with direct cardiac effects
|
|
|
|
|
C08DA
|
|
Phenylalkylamine derivatives
|
|
|
|
|
|
C08DA01
|
Verapamil
|
|
|
|
|
|
C08DA02
|
Gallopamil
|
|
|
|
|
|
C08DA51
|
Verapamil, combinations
|
|
|
|
|
C08DB
|
|
Benzothiazepine derivatives
|
|
|
|
|
|
C08DB01
|
Diltiazem
|
|
|
|
C08E
|
|
|
Non-selective calcium channel blockers
|
|
|
|
|
C08EA
|
|
Phenylalkylamine derivatives
|
|
|
|
|
|
C08EA01
|
Fendiline
|
|
|
|
|
|
C08EA02
|
Bepridil
|
|
|
|
|
C08EX
|
|
Other non-selective calcium channel blockers
|
|
|
|
|
|
C08EX01
|
Lidoflazine
|
|
|
|
|
|
C08EX02
|
Perhexiline
|
|
|
|
C08G
|
|
|
Calcium channel blockers and diuretics
|
|
|
|
|
C08GA
|
|
Calcium channel blockers and diuretics
|
|
|
|
|
|
C08GA01
|
Nifedipine and diuretics
|
|
|
C09
|
|
|
|
Agents acting on the renin-angiotensin system
|
|
|
|
C09A
|
|
|
ACE inhibitors, plain
|
|
|
|
|
C09AA
|
|
ACE inhibitors, plain
|
|
|
|
|
|
C09AA01
|
Captopril
|
|
|
|
|
|
C09AA02
|
Enalapril
|
|
|
|
|
|
C09AA03
|
Lisinopril
|
|
|
|
|
|
C09AA04
|
Perindopril
|
|
|
|
|
|
C09AA05
|
Ramipril
|
|
|
|
|
|
C09AA06
|
Quinaprl
|
|
|
|
|
|
C09AA07
|
Benazepril
|
|
|
|
|
|
C09AA08
|
Cilazapril
|
|
|
|
|
|
C09AA09
|
Fosinopril
|
|
|
|
|
|
C09AA10
|
Trandolapril
|
|
|
|
|
|
C09AA11
|
Spirapril
|
|
|
|
|
|
C09AA12
|
Delapril
|
|
|
|
|
|
C09AA13
|
Moexipril
|
|
|
|
|
|
C09AA14
|
Temocapril
|
|
|
|
|
|
C09AA15
|
Zofenopril
|
|
|
|
|
|
C09AA16
|
Imidapril
|
|
|
|
C09B
|
|
|
ACE inhibitors, combinations
|
|
|
|
|
C09BA
|
|
ACE inhibitors and diuretics
|
|
|
|
|
|
C09BA01
|
Captopril and diuretics
|
|
|
|
|
|
C09BA02
|
Enalapril and diuretics
|
|
|
|
|
|
C09BA03
|
Lisinopril and diuretics
|
|
|
|
|
|
C09BA04
|
Perindopril and diuretics
|
|
|
|
|
|
C09BA05
|
Ramipril and diuretics
|
|
|
|
|
|
C09BA06
|
Quinapril and diuretics
|
|
|
|
|
|
C09BA07
|
Benazepril and diuretics
|
|
|
|
|
|
C09BA08
|
Cilazapril and diuretics
|
|
|
|
|
|
C09BA09
|
Fosinopril and diuretics
|
|
|
|
|
|
C09BA12
|
Delapril and diuretics
|
|
|
|
|
|
C09BA13
|
Moexipril and diuretics
|
|
|
|
|
|
C09BA15
|
Zofenopril and diuretics
בעבודה
|
|
|
|
|
C09BB
|
|
ACE inhibitors and calcium channel blockers
|
|
|
|
|
|
C09BB02
|
Enalapril and lercanidipine
|
|
|
|
|
|
C09BB03
|
Lisinopril and amlodipine
|
|
|
|
|
|
C09BB04
|
Perindopril and amlodipine
|
|
|
|
|
|
C09BB05
|
Ramipril and felodipine
|
|
|
|
|
|
C09BB06
|
Enalapril and nitrendipine
|
|
|
|
|
|
C09BB07
|
Ramipril and amlodipine
|
|
|
|
|
|
C09BB10
|
Trandolapril and verapamil
|
|
|
|
|
|
C09BB12
|
Delapril and manidipine
|
|
|
|
C09C
|
|
|
Angiotensin II antagonists, plain
|
|
|
|
|
C09CA
|
|
Angiotensin II antagonists, plain
|
|
|
|
C09D
|
|
|
Angiotensin II antagonists, combinations
|
|
|
|
|
C09DA
|
|
Angiotensin II antagonists and diuretics
|
|
|
|
|
C09DB
|
|
Angiotensin II antagonists and calcium channel blockers
|
|
|
|
|
C09DX
|
|
Angiotensin II antagonists, other combinations
|
|
|
|
C09X
|
|
|
Other agents acting on the renin-angiotensin system
|
|
|
|
|
C09XA
|
|
Renin-inhibitors
|
|
|
|
|
|
|
להשלים
|
|
|
C10
|
|
|
|
Lipid modifying agents
|
|
|
|
C10A
|
|
|
Lipid modifying agents, plain
|
|
|
|
|
C10AA
|
|
HMG CoA reductase inhibitors
|
|
|
|
|
C10AB
|
|
Fibrates
|
|
|
|
|
C10AC
|
|
Bile acid sequestrants
|
|
|
|
|
|
C10AC01
|
Colestyramine
|
|
|
|
|
|
C10AC02
|
Colestipol
|
|
|
|
|
|
C10AC03
|
Colextran
|
|
|
|
|
|
C10AC04
|
Colesevelam
|
|
|
|
|
C10AD
|
|
Nicotinic acid and derivatives
|
|
|
|
|
C10AX
|
|
Other lipid modifying agents
|
|
|
|
C10B
|
|
|
Lipid modifying agents, combinations
|
| D
|
|
|
|
|
Dermatologicals
|
|
|
D01
|
|
|
|
Antifungals for dermatological use
|
|
|
D02
|
|
|
|
Emollients and protectives
|
|
|
D03
|
|
|
|
Preparations for treatment of wounds and ulcers
|
|
|
D04
|
|
|
|
Antipruritics, including antihistamines, anesthetics, etc
|
|
|
D05
|
|
|
|
Antipsoriatics
|
|
|
D06
|
|
|
|
Antibiotics and chemotherapeutics for dermatological use
|
|
|
D07
|
|
|
|
Corticosteroids, dermatological preparations
|
|
|
D08
|
|
|
|
Antiseptics and disinfectants
|
|
|
D09
|
|
|
|
Medicated dressings
|
|
|
D10
|
|
|
|
Anti-acne preparations
|
|
|
D11
|
|
|
|
Other dermatological preparations
|
| G
|
|
|
|
|
Genito-urinary system and sex hormones
|
|
|
G01
|
|
|
|
Gynecological antiinfectives and antiseptics
|
|
|
G02
|
|
|
|
Other gynecologicals
|
|
|
G03
|
|
|
|
Sex hormones and modulators of the genital system
|
|
|
G04
|
|
|
|
Urologicals
|
|
|
|
G04B
|
|
|
Urologicals
|
|
|
|
|
G04BA
|
|
Acidifiers
|
|
|
|
|
G04BC
|
|
Urinary concrement solvents
|
|
|
|
|
G04BD
|
|
Drugs for urinary frequency and incontinence
|
|
|
|
|
|
G04BD01
|
Emepronium
|
|
|
|
|
|
G04BD02
|
Flavoxate
|
|
|
|
|
|
G04BD03
|
Meladrazine
|
|
|
|
|
|
G04BD04
|
Oxybutynin
|
|
|
|
|
|
G04BD05
|
Terodiline
|
|
|
|
|
|
G04BD06
|
Propiverine
|
|
|
|
|
|
G04BD07
|
Tolterodine
|
|
|
|
|
|
G04BD08
|
Solifenacin
|
|
|
|
|
|
G04BD09
|
Trospium
|
|
|
|
|
|
G04BD10
|
Darifenacin
|
|
|
|
|
|
G04BD11
|
Fesoterodine
|
|
|
|
|
|
G04BD12
|
Mirabegron
|
|
|
|
|
G04BE
|
|
Drugs used in erectile dysfunction
|
|
|
|
|
|
G04BE01
|
Alprostadil
|
|
|
|
|
|
G04BE02
|
Papaverine
|
|
|
|
|
|
G04BE03
|
Sildenafil
|
|
|
|
|
|
G04BE04
|
Yohimbin
|
|
|
|
|
|
G04BE06
|
Moxisylyte
|
|
|
|
|
|
G04BE07
|
Apomorphine
|
|
|
|
|
|
G04BE08
|
Tadalafil
|
|
|
|
|
|
G04BE09
|
Vardenafil
|
|
|
|
|
|
G04BE30
|
Combinations
|
|
|
|
|
|
G04BE52
|
Papaverine, combinations
|
|
|
|
|
G04BX
|
|
Other urologicals
|
|
|
|
|
|
|
להשלים
|
|
|
|
G04C
|
|
|
Drugs used in benign prostatic hypertrophy
|
|
|
|
|
G04CA
|
|
Alpha-adrenoreceptor antagonists
|
|
|
|
|
G04CB
|
|
Testosterone-5-alpha reductase inhibitors
|
|
|
|
|
G04CX
|
|
Other drugs used in benign prostatic hypertrophy
|
| H
|
|
|
|
|
Systemic hormonal preparations, excluding sex hormones and insulins
|
|
|
H01
|
|
|
|
Pituitary and hypothalamic hormones and analogues
|
|
|
H02
|
|
|
|
Corticosteroids for systemic use
|
|
|
H03
|
|
|
|
Thyroid therapy
|
|
|
H04
|
|
|
|
Pancreatic hormones
|
|
|
H05
|
|
|
|
Calcium homeostasis
|
| J
|
|
|
|
|
Antiinfectives for systemic use
|
|
|
J01
|
|
|
|
Antibacterials for systemic use
|
|
|
|
J01A
|
|
|
Tetracyclines
|
|
|
|
J01B
|
|
|
Amphenicols
|
|
|
|
J01C
|
|
|
Beta-lactam antibacterials, penicillins
|
|
|
|
J01D
|
|
|
Other beta-lactam antibacterials
|
|
|
|
J01E
|
|
|
Sulfonamides and trimethoprim
|
|
|
|
J01F
|
|
|
Macrolides, lincosamides and streptogramins
|
|
|
|
J01G
|
|
|
Aminoglycoside antibacterials
|
|
|
|
J01M
|
|
|
Quinolone antibacterials
|
|
|
|
J01R
|
|
|
Combinations of antibacterials
|
|
|
|
J01X
|
|
|
Other antibacterials
|
|
|
|
|
J01XA
|
|
Glycopeptide antibacterials
|
|
|
|
|
J01XB
|
|
Polymyxins
|
|
|
|
|
J01XC
|
|
Steroid antibacterials
|
|
|
|
|
J01XD
|
|
Imidazole derivatives
|
|
|
|
|
J01XE
|
|
Nitrofuran derivatives
|
|
|
|
|
J01XX
|
|
Other antibacterials
|
|
|
J02
|
|
|
|
Antimycotics for systemic use
|
|
|
J04
|
|
|
|
Antimycobacterials
|
|
|
J05
|
|
|
|
Antivirals for systemic use
|
|
|
|
J05A
|
|
|
Direct acting antiviral drugs
|
|
|
|
|
J05AA
|
|
Thiosemicarbazones
|
|
|
|
|
J05AB
|
|
Nucleosides and nucleotides excluding reverse transcriptase inhibitors
|
|
|
|
|
J05AC
|
|
Cyclic amines
|
|
|
|
|
J05AD
|
|
Phosphonic acid derivatives
|
|
|
|
|
J05AE
|
|
Protease inhibitors
|
|
|
|
|
J05AF
|
|
Nucleoside and nucleotide reverse transcriptase inhibitors
|
|
|
|
|
|
J05AF01
|
Zidovudine
|
|
|
|
|
|
J05AF02
|
Didanosine
|
|
|
|
|
|
J05AF03
|
Zalcitabine
|
|
|
|
|
|
J05AF04
|
Stavudine
|
|
|
|
|
|
J05AF05
|
Lamivudine
|
|
|
|
|
|
J05AF06
|
Abacavir
|
|
|
|
|
|
J05AF07
|
Tenofovir disoproxil
|
|
|
|
|
|
J05AF08
|
Adefovir dipivoxil
|
|
|
|
|
|
J05AF09
|
Emtricitabine
|
|
|
|
|
|
J05AF10
|
Entecavir
|
|
|
|
|
|
J05AF11
|
Telbivudine
|
|
|
|
|
|
J05AF12
|
Clevudine
|
|
|
|
|
J05AG
|
|
Non-nucleoside reverse transcriptase inhibitors
|
|
|
|
|
|
J05AG01
|
Nevirapine
|
|
|
|
|
|
J05AG02
|
Delavirdine
|
|
|
|
|
|
J05AG03
|
Efavirenz
|
|
|
|
|
|
J05AG04
|
Etravirine
|
|
|
|
|
|
J05AG05
|
Rilpivirine
|
|
|
|
|
J05AH
|
|
Neuraminidase inhibitors
|
|
|
|
|
|
J05AH01
|
Zanamivir
|
|
|
|
|
|
J05AH02
|
Oseltamivir
|
|
|
|
|
J05AR
|
|
Antivirals for treatment of HIV infections, combinations
|
|
|
|
|
|
J05AR01
|
Zidovudine and lamivudine
|
|
|
|
|
|
J05AR02
|
Lamivudine and abacavir
|
|
|
|
|
|
J05AR03
|
Tenofovir disoproxil and emtricitabine
|
|
|
|
|
|
J05AR04
|
Zidovudine, lamivudine and abacavir
|
|
|
|
|
|
J05AR05
|
Zidovudine, lamivudine and nevirapine
|
|
|
|
|
|
J05AR06
|
Emtricitabine, tenofovir disoproxil and efavirenz
|
|
|
|
|
|
J05AR07
|
Stavudine, lamivudine and nevirapine
|
|
|
|
|
|
J05AR08
|
Emtricitabine, tenofovir disoproxil and rilpivirine
|
|
|
|
|
|
J05AR09
|
Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
|
|
|
|
|
|
J05AR10
|
Lopinavir and ritonavir
|
|
|
|
|
J05AX
|
|
Other antivirals
|
|
|
|
|
|
J05AX01
|
Moroxydine
|
|
|
|
|
|
J05AX02
|
Lysozyme
|
|
|
|
|
|
J05AX05
|
Inosine pranobex
|
|
|
|
|
|
J05AX06
|
Pleconaril
|
|
|
|
|
|
J05AX07
|
Enfuvirtide
|
|
|
|
|
|
J05AX08
|
Raltegravir
|
|
|
|
|
|
J05AX09
|
Maraviroc
|
|
|
|
|
|
J05AX10
|
Maribavir
|
|
|
|
|
|
J05AX11
|
Elvitegravir
|
|
|
J06
|
|
|
|
Immune sera and immunoglobulins
|
|
|
|
J06A
|
|
|
Immune sera
|
|
|
|
|
J06AA
|
|
Immune sera
|
|
|
|
|
|
J06AA01
|
Diphtheria antitoxin
|
|
|
|
|
|
J06AA02
|
Tetanus antitoxin
|
|
|
|
|
|
J06AA03
|
Snake venom antiserum
|
|
|
|
|
|
J06AA04
|
Botulinum antitoxin
|
|
|
|
|
|
J06AA05
|
Gas-gangrene sera
|
|
|
|
|
|
J06AA06
|
Rabies serum
|
|
|
|
J06B
|
|
|
Immunoglobulins
|
|
|
|
|
J06BA
|
|
Immunoglobulins, normal human
|
|
|
|
|
|
J06BA01
|
Immunoglobulins, normal human, for extravascular administration
|
|
|
|
|
|
J06BA02
|
Immunoglobulins, normal human, for intravascular administration
|
|
|
|
|
J06BB
|
|
Specific immunoglobulins
|
|
|
|
|
|
J06BB01
|
Anti-D (rh) immunoglobulin
|
|
|
|
|
|
J06BB02
|
Tetanus immunoglobulin
|
|
|
|
|
|
J06BB03
|
Varicella/zoster immunoglobulin
|
|
|
|
|
|
J06BB04
|
Hepatitis B immunoglobulin
|
|
|
|
|
|
J06BB05
|
Rabies immunoglobulin
|
|
|
|
|
|
J06BB06
|
Rubella immunoglobulin
|
|
|
|
|
|
J06BB07
|
Vaccinia immunoglobulin
|
|
|
|
|
|
J06BB08
|
Staphylococcus immunoglobulin
|
|
|
|
|
|
J06BB09
|
Cytomegalovirus immunoglobulin
|
|
|
|
|
|
J06BB10
|
Diphtheria immunoglobulin
|
|
|
|
|
|
J06BB11
|
Hepatitis A immunoglobulin
|
|
|
|
|
|
J06BB12
|
Encephalitis, tick borne immunoglobulin
|
|
|
|
|
|
J06BB13
|
Pertussis immunoglobulin
|
|
|
|
|
|
J06BB14
|
Morbilli immunoglobulin
|
|
|
|
|
|
J06BB15
|
Parotitis immunoglobulin
|
|
|
|
|
|
J06BB16
|
Palivizumab
|
|
|
|
|
|
J06BB17
|
Motavizumab
|
|
|
|
|
|
J06BB30
|
Combinations
|
|
|
|
|
J06BC
|
|
Other immunoglobulins
|
|
|
|
|
|
J06BC01
|
Nebacumab
|
| L
|
|
|
|
|
Antineoplastic and immunomodulating agents
|
|
|
L01
|
|
|
|
Antineoplastic agents
|
|
|
|
L01A
|
|
|
Alkylating agents
|
|
|
|
|
L01AA
|
|
Nitrogen mustard analogues
|
|
|
|
|
|
L01AA01
|
Cyclophosphamide
|
|
|
|
|
|
L01AA02
|
Chlorambucil
|
|
|
|
|
|
L01AA03
|
Melphalan
|
|
|
|
|
|
L01AA05
|
Chlormethine
|
|
|
|
|
|
L01AA06
|
Ifosfamide
|
|
|
|
|
|
L01AA07
|
Trofosfamide
|
|
|
|
|
|
L01AA08
|
Prednimustine
|
|
|
|
|
|
L01AA09
|
Bendamustine
|
|
|
|
|
L01AB
|
|
Alkyl sulfonates
|
|
|
|
|
|
L01AB01
|
Busulfan
|
|
|
|
|
|
L01AB02
|
Treosulfan
|
|
|
|
|
|
L01AB03
|
Mannosulfan
|
|
|
|
|
L01AC
|
|
Ethylene imines
|
|
|
|
|
|
L01AC01
|
Thiotepa
|
|
|
|
|
|
L01AC02
|
Triaziquone
|
|
|
|
|
|
L01AC03
|
Carboquone
|
|
|
|
|
L01AD
|
|
Nitrosoureas
|
|
|
|
|
|
L01AD01
|
Carmustine
|
|
|
|
|
|
L01AD02
|
Lomustine
|
|
|
|
|
|
L01AD03
|
Semustine
|
|
|
|
|
|
L01AD04
|
Streptozocin
|
|
|
|
|
|
L01AD05
|
Fotemustine
|
|
|
|
|
|
L01AD06
|
Nimustine
|
|
|
|
|
|
L01AD07
|
Ranimustine
|
|
|
|
|
L01AG
|
|
Epoxides
|
|
|
|
|
|
L01AG01
|
Etoglucid
|
|
|
|
|
L01AX
|
|
Other alkylating agents
|
|
|
|
|
|
L01AX01
|
Mitobronitol
|
|
|
|
|
|
L01AX02
|
Pipobroman
|
|
|
|
|
|
L01AX03
|
Temozolomide
|
|
|
|
|
|
L01AX04
|
Dacarbazine
|
|
|
|
L01B
|
|
|
Antimetabolites
|
|
|
|
|
L01BA
|
|
Folic acid analogues
|
|
|
|
|
|
L01BA01
|
Methotrexate
|
|
|
|
|
|
L01BA03
|
Raltitrexed
|
|
|
|
|
|
L01BA04
|
Pemetrexed
|
|
|
|
|
|
L01BA05
|
Pralatrexate
|
|
|
|
|
L01BB
|
|
Purine analogues
|
|
|
|
|
|
L01BB02
|
Mercaptopurine
|
|
|
|
|
|
L01BB03
|
Tioguanine
|
|
|
|
|
|
L01BB04
|
Cladribine
|
|
|
|
|
|
L01BB05
|
Fludarabine
|
|
|
|
|
|
L01BB06
|
Clofarabine
|
|
|
|
|
|
L01BB07
|
Nelarabine
|
|
|
|
|
L01BC
|
|
Pyrimidine analogues
|
|
|
|
|
|
L01BC01
|
Cytarabine
|
|
|
|
|
|
L01BC02
|
Fluorouracil
|
|
|
|
|
|
L01BC03
|
Tegafur
|
|
|
|
|
|
L01BC04
|
Carmofur
|
|
|
|
|
|
L01BC05
|
Gemcitabine
|
|
|
|
|
|
L01BC06
|
Capecitabine
|
|
|
|
|
|
L01BC07
|
Azacitidine
|
|
|
|
|
|
L01BC08
|
Decitabine
|
|
|
|
|
|
L01BC52
|
Fluorouracil, combinations
|
|
|
|
|
|
L01BC53
|
Tegafur, combinations
|
|
|
|
L01C
|
|
|
Plant alkaloids and other natural products
|
|
|
|
|
L01CA
|
|
Vinca alkaloids and analogues
|
|
|
|
|
|
L01CA01
|
Vinblastine
|
|
|
|
|
|
L01CA02
|
Vincristine
|
|
|
|
|
|
L01CA03
|
Vindesine
|
|
|
|
|
|
L01CA04
|
Vinorelbine
|
|
|
|
|
|
L01CA05
|
Vinflunine
|
|
|
|
|
L01CB
|
|
Podophyllotoxin derivatives
|
|
|
|
|
|
L01CB01
|
Etoposide
|
|
|
|
|
|
L01CB02
|
Teniposide
|
|
|
|
|
L01CC
|
|
Colchicine derivatives
|
|
|
|
|
|
L01CC01
|
Demecolcine
|
|
|
|
|
L01CD
|
|
Taxanes
|
|
|
|
|
|
L01CD01
|
Paclitaxel
|
|
|
|
|
|
L01CD02
|
Docetaxel
|
|
|
|
|
|
L01CD03
|
Paclitaxel poliglumex
|
|
|
|
|
|
L01CD04
|
Cabazitaxel
|
|
|
|
|
L01CX
|
|
Other plant alkaloids and natural products
|
|
|
|
|
|
L01CX01
|
Trabectedin
|
|
|
|
L01D
|
|
|
Cytotoxic antibiotics and related substances
|
|
|
|
|
L01DA
|
|
Actinomycines
|
|
|
|
|
|
L01DA01
|
Dactinomycin
|
|
|
|
|
L01DB
|
|
Anthracyclines and related substances
|
|
|
|
|
|
L01DB01
|
Doxorubicin
|
|
|
|
|
|
L01DB02
|
Daunorubicin
|
|
|
|
|
|
L01DB03
|
Epirubicin
|
|
|
|
|
|
L01DB04
|
Aclarubicin
|
|
|
|
|
|
L01DB05
|
Zorubicin
|
|
|
|
|
|
L01DB06
|
Idarubicin
|
|
|
|
|
|
L01DB07
|
Mitoxantrone
|
|
|
|
|
|
L01DB08
|
Pirarubicin
|
|
|
|
|
|
L01DB09
|
Valrubicin
|
|
|
|
|
|
L01DB10
|
Amrubicin
|
|
|
|
|
|
L01DB11
|
Pixantrone
|
|
|
|
|
L01DC
|
|
Other cytotoxic antibiotics
|
|
|
|
|
|
L01DC01
|
Bleomycin
|
|
|
|
|
|
L01DC02
|
Plicamycin
|
|
|
|
|
|
L01DC03
|
Mitomycin
|
|
|
|
|
|
L01DC04
|
Ixabepilone
|
|
|
|
L01X
|
|
|
Other antineoplastic agents
|
|
|
|
|
L01XA
|
|
Platinum compounds
|
|
|
|
|
|
L01XA01
|
Cisplatin
|
|
|
|
|
|
L01XA02
|
Carboplatin
|
|
|
|
|
|
L01XA03
|
Oxaliplatin
|
|
|
|
|
|
L01XA04
|
Satraplatin
|
|
|
|
|
|
L01XA05
|
Polyplatillen
|
|
|
|
|
L01XB
|
|
Methylhydrazines
|
|
|
|
|
|
L01XB01
|
Procarbazine
|
|
|
|
|
L01XC
|
|
Monoclonal antibodies
|
|
|
|
|
|
L01XC01
|
Edrecolomab
|
|
|
|
|
|
L01XC02
|
Rituximab
|
|
|
|
|
|
L01XC03
|
Trastuzumab
|
|
|
|
|
|
L01XC04
|
Alemtuzumab
|
|
|
|
|
|
L01XC05
|
Gemtuzumab
|
|
|
|
|
|
L01XC06
|
Cetuximab
|
|
|
|
|
|
L01XC07
|
Bevacizumab
|
|
|
|
|
|
L01XC08
|
Panitumumab
|
|
|
|
|
|
L01XC09
|
Catumaxomab
|
|
|
|
|
|
L01XC10
|
Ofatumumab
|
|
|
|
|
|
L01XC11
|
Ipilimumab
|
|
|
|
|
|
L01XC12
|
Brentuximab vedotin
|
|
|
|
|
|
L01XC13
|
Pertuzumab
|
|
|
|
|
L01XD
|
|
Sensitizers used in photodynamic/radiation therapy
|
|
|
|
|
|
L01XD01
|
Porfimer sodium
|
|
|
|
|
|
L01XD03
|
Methyl aminolevulinate
|
|
|
|
|
|
L01XD04
|
Aminolevulinic acid
|
|
|
|
|
|
L01XD05
|
Temoporfin
|
|
|
|
|
|
L01XD06
|
Efaproxiral
|
|
|
|
|
L01XE
|
|
Protein kinase inhibitors
|
|
|
|
|
|
L01XE01
|
Imatinib
|
|
|
|
|
|
L01XE02
|
Gefitinib
|
|
|
|
|
|
L01XE03
|
Erlotinib
|
|
|
|
|
|
L01XE04
|
Sunitinib
|
|
|
|
|
|
L01XE05
|
Sorafenib
|
|
|
|
|
|
L01XE06
|
Dasatinib
|
|
|
|
|
|
L01XE07
|
Lapatinib
|
|
|
|
|
|
L01XE08
|
Nilotinib
|
|
|
|
|
|
L01XE09
|
Temsirolimus
|
|
|
|
|
|
L01XE10
|
Everolimus
|
|
|
|
|
|
L01XE11
|
Pazopanib
|
|
|
|
|
|
L01XE12
|
Vandetanib
|
|
|
|
|
|
L01XE13
|
Afatinib
|
|
|
|
|
|
L01XE14
|
Bosutinib
|
|
|
|
|
|
L01XE15
|
Vemurafenib
|
|
|
|
|
|
L01XE16
|
Crizotinib
|
|
|
|
|
|
L01XE17
|
Axitinib
|
|
|
|
|
|
L01XE18
|
Ruxolitinib
|
|
|
|
|
|
L01XE19
|
Ridaforolimus
|
|
|
|
|
|
L01XE21
|
Regorafenib
|
|
|
|
|
|
L01XE22
|
Masitinib
|
|
|
|
|
L01XX
|
|
Other antineoplastic agents
|
|
|
|
|
|
L01XX01
|
Amsacrine
|
|
|
|
|
|
L01XX02
|
Asparaginase
|
|
|
|
|
|
L01XX03
|
Altretamine
|
|
|
|
|
|
L01XX05
|
Hydroxycarbamide
|
|
|
|
|
|
L01XX07
|
Lonidamine
|
|
|
|
|
|
L01XX08
|
Pentostatin
|
|
|
|
|
|
L01XX09
|
Miltefosine
|
|
|
|
|
|
L01XX10
|
Masoprocol
|
|
|
|
|
|
L01XX11
|
Estramustine
|
|
|
|
|
|
L01XX14
|
Tretinoin
|
|
|
|
|
|
L01XX16
|
Mitoguazone
|
|
|
|
|
|
L01XX17
|
Topotecan
|
|
|
|
|
|
L01XX18
|
Tiazofurine
|
|
|
|
|
|
L01XX19
|
Irinotecan
|
|
|
|
|
|
L01XX22
|
Alitretinoin
|
|
|
|
|
|
L01XX23
|
Mitotane
|
|
|
|
|
|
L01XX24
|
Pegaspargase
|
|
|
|
|
|
L01XX25
|
Bexarotene
|
|
|
|
|
|
L01XX27
|
Arsenic trioxide
|
|
|
|
|
|
L01XX29
|
Denileukin diftitox
|
|
|
|
|
|
L01XX32
|
Bortezomib
|
|
|
|
|
|
L01XX33
|
Celecoxib
|
|
|
|
|
|
L01XX35
|
Anagrelide
|
|
|
|
|
|
L01XX36
|
Oblimersen
|
|
|
|
|
|
L01XX37
|
Sitimagene ceradenovec
|
|
|
|
|
|
L01XX38
|
Vorinostat
|
|
|
|
|
|
L01XX39
|
Romidepsin
|
|
|
|
|
|
L01XX40
|
Omacetaxine mepesuccinate
|
|
|
|
|
|
L01XX41
|
Eribulin
|
|
|
|
|
|
L01XX42
|
Panobinostat
|
|
|
|
|
|
L01XX43
|
Vismodegib
|
|
|
|
|
L01XY
|
|
Combinations of antineoplastic agents
|
|
|
|
|
|
|
EMPTY
|
|
|
L02
|
|
|
|
Endocrine therapy
|
|
|
L03
|
|
|
|
Immunostimulants
|
|
|
L04
|
|
|
|
Immunosuppressants
|
| M
|
|
|
|
|
Musculo-skeletal system
|
|
|
M01
|
|
|
|
Anti-inflammatory and antirheumatic products
|
|
|
|
M01A
|
|
|
Anti-inflammatory and antirheumatic products, non-steroids
|
|
|
|
|
M01AA
|
|
Butylpyrazolidines
|
|
|
|
|
M01AB
|
|
Acetic acid derivatives and related substances
|
|
|
|
|
|
M01AB01
|
Indometacin
|
|
|
|
|
|
M01AB02
|
Sulindac
|
|
|
|
|
|
M01AB03
|
Tolmetin
|
|
|
|
|
|
M01AB04
|
Zomepirac
|
|
|
|
|
|
M01AB05
|
Diclofenac
|
|
|
|
|
|
M01AB06
|
Alclofenac
|
|
|
|
|
|
M01AB07
|
Bumadizone
|
|
|
|
|
|
M01AB08
|
Etodolac
|
|
|
|
|
|
M01AB09
|
Lonazolac
|
|
|
|
|
|
M01AB10
|
Fentiazac
|
|
|
|
|
|
M01AB11
|
Acemetacin
|
|
|
|
|
|
M01AB12
|
Difenpiramide
|
|
|
|
|
|
M01AB13
|
Oxametacin
|
|
|
|
|
|
M01AB14
|
Proglumetacin
|
|
|
|
|
|
M01AB15
|
Ketorolac
|
|
|
|
|
|
M01AB16
|
Aceclofenac
|
|
|
|
|
|
M01AB17
|
Bufexamac
|
|
|
|
|
|
M01AB51
|
Indometacin, combinations
|
|
|
|
|
|
M01AB55
|
Diclofenac, combinations
|
|
|
|
|
M01AC
|
|
Oxicams
|
|
|
|
|
M01AE
|
|
Propionic acid derivatives
|
|
|
|
|
M01AG
|
|
Fenamates
|
|
|
|
|
M01AH
|
|
Coxibs
|
|
|
|
|
M01AX
|
|
Other anti-inflammatory and antirheumatic agents, non-steroids
|
|
|
|
|
|
M01AX01
|
Nabumetone
|
|
|
|
|
|
M01AX02
|
Niflumic acid
|
|
|
|
|
|
M01AX04
|
Azapropazone
|
|
|
|
|
|
M01AX05
|
Glucosamine
|
|
|
|
|
|
M01AX07
|
Benzydamine
|
|
|
|
|
|
M01AX12
|
Glucosaminoglycan polysulfate
|
|
|
|
|
|
M01AX13
|
Proquazone
|
|
|
|
|
|
M01AX14
|
Orgotein
|
|
|
|
|
|
M01AX17
|
Nimesulide
|
|
|
|
|
|
M01AX18
|
Feprazone
|
|
|
|
|
|
M01AX21
|
Diacerein
|
|
|
|
|
|
M01AX22
|
Morniflumate
|
|
|
|
|
|
M01AX23
|
Tenidap
|
|
|
|
|
|
M01AX24
|
Oxaceprol
|
|
|
|
|
|
M01AX25
|
Chondroitin sulfate
|
|
|
|
|
|
M01AX26
|
Avocado and soyabean oil, unsaponifiables
|
|
|
|
|
|
M01AX68
|
Feprazone, combinations
|
|
|
|
M01B
|
|
|
Anti-inflammatory/antirheumatic agents in combination
|
|
|
|
M01C
|
|
|
Specific antirheumatic agents
|
|
|
M02
|
|
|
|
Topical products for joint and muscular pain
|
|
|
|
M02A
|
|
|
Topical products for joint and muscular pain
|
|
|
|
|
M02AA
|
|
Anti-inflammatory preparations, non-steroids for topical use
|
|
|
|
|
|
M02AA01
|
Phenylbutazone
|
|
|
|
|
|
M02AA02
|
Mofebutazone
|
|
|
|
|
|
M02AA03
|
Clofezone
|
|
|
|
|
|
M02AA04
|
Oxyphenbutazone
|
|
|
|
|
|
M02AA05
|
Benzydamine
|
|
|
|
|
|
M02AA06
|
Etofenamate
|
|
|
|
|
|
M02AA07
|
Piroxicam
|
|
|
|
|
|
M02AA08
|
Felbinac
|
|
|
|
|
|
M02AA09
|
Bufexamac
|
|
|
|
|
|
M02AA10
|
Ketoprofen
|
|
|
|
|
|
M02AA11
|
Bendazac
|
|
|
|
|
|
M02AA12
|
Naproxen
|
|
|
|
|
|
M02AA13
|
Ibuprofen
|
|
|
|
|
|
M02AA14
|
Fentiazac
|
|
|
|
|
|
M02AA15
|
Diclofenac
|
|
|
|
|
|
M02AA16
|
Feprazone
|
|
|
|
|
|
M02AA17
|
Niflumic acid
|
|
|
|
|
|
M02AA18
|
Meclofenamic acid
|
|
|
|
|
|
M02AA19
|
Flurbiprofen
|
|
|
|
|
|
M02AA21
|
Tolmetin
|
|
|
|
|
|
M02AA22
|
Suxibuzone
|
|
|
|
|
|
M02AA23
|
Indometacin
|
|
|
|
|
|
M02AA24
|
Nifenazone
|
|
|
|
|
|
M02AA25
|
Aceclofenac
|
|
|
|
|
|
M02AA26
|
Nimesulide
|
|
|
|
|
M02AB
|
|
Capsaicin and similar agents
|
|
|
|
|
M02AC
|
|
Preparations with salicylic acid derivatives
|
|
|
|
|
M02AX
|
|
Other topical products for joint and muscular pain
|
|
|
M03
|
|
|
|
Muscle relaxants
|
|
|
M04
|
|
|
|
Antigout preparations
|
|
|
M05
|
|
|
|
Drugs for treatment of bone diseases
|
|
|
M09
|
|
|
|
Other drugs for disorders of the musculo-skeletal system
|
| N
|
|
|
|
|
Nervous system
|
|
|
N01
|
|
|
|
Anesthetics
|
|
|
N02
|
|
|
|
Analgesics
|
|
|
N03
|
|
|
|
Antiepileptics
|
|
|
N04
|
|
|
|
Anti-parkinson drugs
|
|
|
N05
|
|
|
|
Psycholeptics
|
|
|
|
N05A
|
|
|
Antipsychotics
|
|
|
|
|
N05AA
|
|
Phenothiazines with aliphatic side-chain
|
|
|
|
|
N05AB
|
|
Phenothiazines with piperazine structure
|
|
|
|
|
N05AC
|
|
Phenothiazines with piperidine structure
|
|
|
|
|
N05AD
|
|
Butyrophenone derivatives
|
|
|
|
|
N05AE
|
|
Indole derivatives
|
|
|
|
|
N05AF
|
|
Thioxanthene derivative
|
|
|
|
|
N05AG
|
|
Diphenylbutylpiperidine derivatives
|
|
|
|
|
N05AH
|
|
Diazepines, oxazepines, thiazepines and oxepines
|
|
|
|
|
N05AL
|
|
Benzamides
|
|
|
|
|
N05AN
|
|
Lithium
|
|
|
|
|
N05AX
|
|
Other antipsychotics
|
|
|
|
|
|
N05AX07
|
Prothipendyl
|
|
|
|
|
|
N05AX08
|
Risperidone
|
|
|
|
|
|
N05AX10
|
Mosapramine
|
|
|
|
|
|
N05AX11
|
Zotepine
|
|
|
|
|
|
N05AX12
|
Aripiprazole
|
|
|
|
|
|
N05AX13
|
Paliperidone
|
|
|
|
|
|
N05AX14
|
Iloperidone
|
|
|
|
N05B
|
|
|
Anxiolytics
|
|
|
|
|
N05BA
|
|
Benzodiazepine derivatives
|
|
|
|
|
|
|
להשלים
|
|
|
|
N05C
|
|
|
Hypnotics and sedatives
|
|
|
N06
|
|
|
|
Psychoanaleptics
|
|
|
N07
|
|
|
|
Other nervous system drugs
|
| P
|
|
|
|
|
Antiparasitic products, insecticides and repellents
|
|
|
P01
|
|
|
|
Antiprotozoals
|
|
|
P02
|
|
|
|
Anthelmintics
|
|
|
P03
|
|
|
|
Ectoparasiticides, including scabicides, insecticides and repellents
|
| R
|
|
|
|
|
Respiratory system
|
|
|
R01
|
|
|
|
Nasal preparations
|
|
|
R02
|
|
|
|
Throat preparations
|
|
|
R03
|
|
|
|
Drugs for obstructive airway diseases
|
|
|
R05
|
|
|
|
Cough and cold preparations
|
|
|
R06
|
|
|
|
Antihistamines for systemic use
|
|
|
R07
|
|
|
|
Other respiratory system products
|
| S
|
|
|
|
|
Sensory organs
|
|
|
S01
|
|
|
|
Ophthalmologicals
|
|
|
S02
|
|
|
|
Otologicals
|
|
|
S03
|
|
|
|
Ophthalmological and otological preparations
|
| V
|
|
|
|
|
Various
|
|
|
V01
|
|
|
|
Allergens
|
|
|
V03
|
|
|
|
All other therapeutic products
|
|
|
V04
|
|
|
|
Diagnostic agents
|
|
|
V06
|
|
|
|
General nutrients
|
|
|
V07
|
|
|
|
All other non-therapeutic products
|
|
|
V08
|
|
|
|
Contrast media
|
|
|
V09
|
|
|
|
Diagnostic radiopharmaceuticals
|
|
|
V10
|
|
|
|
Therapeutic radiopharmaceuticals
|
|
|
V20
|
|
|
|
Surgical dressings
|
כניסה 
עקבו אחרינו בפייסבוק